JPH08286332A - Processing method for silver halide photosensitive material - Google Patents
Processing method for silver halide photosensitive materialInfo
- Publication number
- JPH08286332A JPH08286332A JP9228195A JP9228195A JPH08286332A JP H08286332 A JPH08286332 A JP H08286332A JP 9228195 A JP9228195 A JP 9228195A JP 9228195 A JP9228195 A JP 9228195A JP H08286332 A JPH08286332 A JP H08286332A
- Authority
- JP
- Japan
- Prior art keywords
- group
- solution
- developing
- processing
- silver halide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 65
- -1 silver halide Chemical class 0.000 title claims abstract description 51
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 47
- 239000004332 silver Substances 0.000 title claims abstract description 47
- 238000003672 processing method Methods 0.000 title abstract description 21
- 238000012545 processing Methods 0.000 claims abstract description 63
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 59
- IKQCSJBQLWJEPU-UHFFFAOYSA-N 2,5-dihydroxybenzenesulfonic acid Chemical compound OC1=CC=C(O)C(S(O)(=O)=O)=C1 IKQCSJBQLWJEPU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000000034 method Methods 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 24
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 125000003277 amino group Chemical group 0.000 claims description 7
- 230000001747 exhibiting effect Effects 0.000 claims description 7
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical group 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 abstract description 24
- 239000000203 mixture Substances 0.000 abstract description 14
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 abstract description 9
- DSVIHYOAKPVFEH-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(CO)CN1C1=CC=CC=C1 DSVIHYOAKPVFEH-UHFFFAOYSA-N 0.000 abstract description 5
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 abstract description 5
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 107
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 48
- 239000000839 emulsion Substances 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- 238000011161 development Methods 0.000 description 24
- 230000018109 developmental process Effects 0.000 description 24
- 239000000126 substance Substances 0.000 description 24
- 238000005406 washing Methods 0.000 description 19
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 17
- 108010010803 Gelatin Proteins 0.000 description 15
- 229920000159 gelatin Polymers 0.000 description 15
- 239000008273 gelatin Substances 0.000 description 15
- 235000019322 gelatine Nutrition 0.000 description 15
- 235000011852 gelatine desserts Nutrition 0.000 description 15
- 239000007788 liquid Substances 0.000 description 15
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 13
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 12
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 12
- 239000011248 coating agent Substances 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 11
- 229910021607 Silver chloride Inorganic materials 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 9
- 229960000583 acetic acid Drugs 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- 239000010419 fine particle Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000010944 silver (metal) Substances 0.000 description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 8
- 235000010724 Wisteria floribunda Nutrition 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 229910001961 silver nitrate Inorganic materials 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 206010070834 Sensitisation Diseases 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000008313 sensitization Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 229960003330 pentetic acid Drugs 0.000 description 5
- 230000005070 ripening Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 230000006911 nucleation Effects 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 239000011241 protective layer Substances 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 description 4
- 235000010265 sodium sulphite Nutrition 0.000 description 4
- 101710134784 Agnoprotein Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- 239000002612 dispersion medium Substances 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 239000006179 pH buffering agent Substances 0.000 description 3
- 239000004848 polyfunctional curative Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 3
- 229940043349 potassium metabisulfite Drugs 0.000 description 3
- 235000010263 potassium metabisulphite Nutrition 0.000 description 3
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 3
- 235000019252 potassium sulphite Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 description 2
- WYMDDFRYORANCC-UHFFFAOYSA-N 2-[[3-[bis(carboxymethyl)amino]-2-hydroxypropyl]-(carboxymethyl)amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)CN(CC(O)=O)CC(O)=O WYMDDFRYORANCC-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- GODCLGCOHHTLHX-UHFFFAOYSA-N 3,3-diphosphonopropanoic acid Chemical compound OC(=O)CC(P(O)(O)=O)P(O)(O)=O GODCLGCOHHTLHX-UHFFFAOYSA-N 0.000 description 2
- GUUULVAMQJLDSY-UHFFFAOYSA-N 4,5-dihydro-1,2-thiazole Chemical class C1CC=NS1 GUUULVAMQJLDSY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 description 2
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 2
- 125000004657 aryl sulfonyl amino group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 239000000022 bacteriostatic agent Substances 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 230000001235 sensitizing effect Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229940001593 sodium carbonate Drugs 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229910052714 tellurium Inorganic materials 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- IWPGKPWCKGMJMG-UHFFFAOYSA-N 1-(4-aminophenyl)-4,4-dimethylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=C(N)C=C1 IWPGKPWCKGMJMG-UHFFFAOYSA-N 0.000 description 1
- QVWJHCMQNBQJJY-UHFFFAOYSA-N 1-[1-(diethylamino)ethyl]-2h-tetrazole-5-thione Chemical compound CCN(CC)C(C)N1NN=NC1=S QVWJHCMQNBQJJY-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- PBKADZMAZVCJMR-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;dihydrate Chemical compound O.O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O PBKADZMAZVCJMR-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 1
- GGRBHXPTYNPANC-UHFFFAOYSA-N 2-nitroindazole Chemical compound C1=CC=CC2=NN([N+](=O)[O-])C=C21 GGRBHXPTYNPANC-UHFFFAOYSA-N 0.000 description 1
- CJAZCKUGLFWINJ-UHFFFAOYSA-N 3,4-dihydroxybenzene-1,2-disulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C(S(O)(=O)=O)=C1O CJAZCKUGLFWINJ-UHFFFAOYSA-N 0.000 description 1
- XWRNOSGOYRPTIC-UHFFFAOYSA-N 3-hydroxy-3-phosphonopropane-1,1,3-tricarboxylic acid Chemical compound OC(=O)C(C(O)=O)CC(O)(C(O)=O)P(O)(O)=O XWRNOSGOYRPTIC-UHFFFAOYSA-N 0.000 description 1
- AJKLCDRWGVLVSH-UHFFFAOYSA-N 4,4-bis(hydroxymethyl)-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(CO)(CO)CN1C1=CC=CC=C1 AJKLCDRWGVLVSH-UHFFFAOYSA-N 0.000 description 1
- IONPWNMJZIUKJZ-UHFFFAOYSA-N 4,4-dimethyl-1-(4-methylphenyl)pyrazolidin-3-one Chemical compound C1=CC(C)=CC=C1N1NC(=O)C(C)(C)C1 IONPWNMJZIUKJZ-UHFFFAOYSA-N 0.000 description 1
- SJSJAWHHGDPBOC-UHFFFAOYSA-N 4,4-dimethyl-1-phenylpyrazolidin-3-one Chemical compound N1C(=O)C(C)(C)CN1C1=CC=CC=C1 SJSJAWHHGDPBOC-UHFFFAOYSA-N 0.000 description 1
- SOVXTYUYJRFSOG-UHFFFAOYSA-N 4-(2-hydroxyethylamino)phenol Chemical compound OCCNC1=CC=C(O)C=C1 SOVXTYUYJRFSOG-UHFFFAOYSA-N 0.000 description 1
- SRYYOKKLTBRLHT-UHFFFAOYSA-N 4-(benzylamino)phenol Chemical compound C1=CC(O)=CC=C1NCC1=CC=CC=C1 SRYYOKKLTBRLHT-UHFFFAOYSA-N 0.000 description 1
- UWOZQBARAREECT-UHFFFAOYSA-N 4-(hydroxymethyl)-4-methyl-1-(4-methylphenyl)pyrazolidin-3-one Chemical compound C1=CC(C)=CC=C1N1NC(=O)C(C)(CO)C1 UWOZQBARAREECT-UHFFFAOYSA-N 0.000 description 1
- BQCIJWPKDPZNHD-UHFFFAOYSA-N 5-bromo-2h-benzotriazole Chemical compound C1=C(Br)C=CC2=NNN=C21 BQCIJWPKDPZNHD-UHFFFAOYSA-N 0.000 description 1
- ZCFMGIGLXOKMJC-UHFFFAOYSA-N 5-butyl-2h-benzotriazole Chemical compound C1=C(CCCC)C=CC2=NNN=C21 ZCFMGIGLXOKMJC-UHFFFAOYSA-N 0.000 description 1
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 description 1
- FIARATPVIIDWJT-UHFFFAOYSA-N 5-methyl-1-phenylpyrazolidin-3-one Chemical compound CC1CC(=O)NN1C1=CC=CC=C1 FIARATPVIIDWJT-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- INVVMIXYILXINW-UHFFFAOYSA-N 5-methyl-1h-[1,2,4]triazolo[1,5-a]pyrimidin-7-one Chemical compound CC1=CC(=O)N2NC=NC2=N1 INVVMIXYILXINW-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- UQLLWWBDSUHNEB-CZUORRHYSA-N Cefaprin Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CSC1=CC=NC=C1 UQLLWWBDSUHNEB-CZUORRHYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102100023328 G-protein coupled estrogen receptor 1 Human genes 0.000 description 1
- 101000829902 Homo sapiens G-protein coupled estrogen receptor 1 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FSVCELGFZIQNCK-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)glycine Chemical compound OCCN(CCO)CC(O)=O FSVCELGFZIQNCK-UHFFFAOYSA-N 0.000 description 1
- JYXGIOKAKDAARW-UHFFFAOYSA-N N-(2-hydroxyethyl)iminodiacetic acid Chemical compound OCCN(CC(O)=O)CC(O)=O JYXGIOKAKDAARW-UHFFFAOYSA-N 0.000 description 1
- WRUZLCLJULHLEY-UHFFFAOYSA-N N-(p-hydroxyphenyl)glycine Chemical compound OC(=O)CNC1=CC=C(O)C=C1 WRUZLCLJULHLEY-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- XMEKHKCRNHDFOW-UHFFFAOYSA-N O.O.[Na].[Na] Chemical compound O.O.[Na].[Na] XMEKHKCRNHDFOW-UHFFFAOYSA-N 0.000 description 1
- 238000001016 Ostwald ripening Methods 0.000 description 1
- 229910021612 Silver iodide Inorganic materials 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- MKBUQYWFFBCMFG-UHFFFAOYSA-N acetic acid propane-1,1-diamine Chemical compound CC(O)=O.CC(O)=O.CC(O)=O.CC(O)=O.CCC(N)N MKBUQYWFFBCMFG-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- PQRDTUFVDILINV-UHFFFAOYSA-N bcdmh Chemical compound CC1(C)N(Cl)C(=O)N(Br)C1=O PQRDTUFVDILINV-UHFFFAOYSA-N 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940111685 dibasic potassium phosphate Drugs 0.000 description 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 1
- 229940090960 diethylenetriamine pentamethylene phosphonic acid Drugs 0.000 description 1
- BBLSYMNDKUHQAG-UHFFFAOYSA-L dilithium;sulfite Chemical compound [Li+].[Li+].[O-]S([O-])=O BBLSYMNDKUHQAG-UHFFFAOYSA-L 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical compound O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- ZZGUZQXLSHSYMH-UHFFFAOYSA-N ethane-1,2-diamine;propanoic acid Chemical compound NCCN.CCC(O)=O.CCC(O)=O ZZGUZQXLSHSYMH-UHFFFAOYSA-N 0.000 description 1
- SAIGUZYNPDJAHY-UHFFFAOYSA-N ethane;2-ethenylsulfonylacetamide Chemical compound CC.NC(=O)CS(=O)(=O)C=C SAIGUZYNPDJAHY-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- IFQUWYZCAGRUJN-UHFFFAOYSA-N ethylenediaminediacetic acid Chemical compound OC(=O)CNCCNCC(O)=O IFQUWYZCAGRUJN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000010946 fine silver Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 239000006224 matting agent Substances 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229940050271 potassium alum Drugs 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 1
- 229940116357 potassium thiocyanate Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229940045105 silver iodide Drugs 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940076133 sodium carbonate monohydrate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- PODWXQQNRWNDGD-UHFFFAOYSA-L sodium thiosulfate pentahydrate Chemical compound O.O.O.O.O.[Na+].[Na+].[O-]S([S-])(=O)=O PODWXQQNRWNDGD-UHFFFAOYSA-L 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 150000003585 thioureas Chemical class 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Silver Salt Photography Or Processing Solution Therefor (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はハロゲン化銀写真感光材
料の現像処理方法に関するものである。FIELD OF THE INVENTION The present invention relates to a method of developing and processing a silver halide photographic light-sensitive material.
【0002】[0002]
【従来の技術】一般に、ハロゲン化銀写真感光材料は露
光後、現像、定着、水洗、乾燥という工程で処理され
る。最近は、そのほとんどが自動現像機(以下自現機と
略称する)を用いて処理される。現像工程は、通常ハイ
ドロキノンに代表されるポリヒドロキシベンゼン類現像
主薬等を含有するアルカリ性の水性現像液組成物を用い
て行われている。すなわち、増感されるハロゲン化銀乳
剤が露光されると、該乳剤のハロゲン化銀粒子中に潜像
が形成され、該潜像は前記現像主薬を含有する現像液中
に該露光乳剤を浸漬することによって現像処理される。
ハイドロキノン等の現像剤は、露光されたハロゲン化銀
粒子を還元することによって、現像された写真映像をも
たらしている。2. Description of the Related Art Generally, a silver halide photographic light-sensitive material is processed in the steps of developing, fixing, washing with water and drying after exposure. Recently, most of them are processed by using an automatic processor (hereinafter, abbreviated as an automatic processor). The developing step is usually carried out using an alkaline aqueous developer composition containing a polyhydroxybenzene type developing agent typified by hydroquinone. That is, when a sensitized silver halide emulsion is exposed to light, a latent image is formed in the silver halide grains of the emulsion, and the latent image is formed by immersing the exposed emulsion in a developing solution containing the developing agent. By doing so, development processing is performed.
Developers such as hydroquinone provide developed photographic images by reducing the exposed silver halide grains.
【0003】ハイドロキノンを現像主薬とする現像液組
成物は多年にわたって問題なく使用されてきているが、
比較的最近になってハイドロキノンの使用によって毒性
と環境破壊に関する問題が提起されるようになった。す
なわち、ハイドロキノンによってもたらされる毒性が原
因となり、この種の組成物を取り扱う人々の健康を保護
するとともに、排出される環境を保護するために法的な
種々の指針や規制に従うことが必要となってきている。
従って、ハイドロキノンに代替えし得る成分であって、
それ自体毒性の低い物質を見いだすことが望ましい。A developer composition containing hydroquinone as a developing agent has been used without problems for many years.
Relatively recently, the use of hydroquinone has raised concerns about toxicity and environmental damage. In other words, due to the toxicity brought about by hydroquinone, it is necessary to comply with various legal guidelines and regulations to protect the health of the people who handle this kind of composition and to protect the discharged environment. ing.
Therefore, a component that can substitute for hydroquinone,
It is desirable to find substances that are themselves less toxic.
【0004】一方、感光材料の現像、定着、水洗、乾燥
を自動的に行う自現機では、処理液、例えば現像液や定
着液を供給する必要性がある。例えば、処理の開始前に
空の処理槽に最初に処理液を供給する場合や、処理され
る感光材料による処理液の持ち出しによって処理槽内の
処理液が減った場合などである。また、自現機には現
像、定着、水洗の各槽に感光材料を順次自動的に搬送す
るための感光材料の通路が設けられており、このため各
処理液と空気との接触面積が大きく、特にローラー型自
現機では開口率が大きくなりやすい。ここで、開口率と
は処理液槽部の処理液と空気の抵触面積cm2 を処理液
槽の処理液量cm3 で割ったものである。現用されてい
る自現機の開口率は一般に0.05〜0.15である。
このように、開口率の大きいことによる空気中の酸素に
よる現像主薬等の現像液成分の酸素酸化に起因するいわ
ゆる経時劣化や、感光材料の処理による現像液や定着液
の消耗によるいわゆる処理疲労を回復するために処理液
又は補充液を処理槽内に供給することが行われる。On the other hand, in an automatic developing machine for automatically developing, fixing, washing with water and drying a photosensitive material, it is necessary to supply a processing solution such as a developing solution and a fixing solution. For example, there is a case where the processing solution is first supplied to an empty processing tank before the start of processing, or a case where the processing solution in the processing tank is reduced by taking out the processing solution by the photosensitive material to be processed. In addition, the automatic developing machine is provided with a passage for the photosensitive material to automatically and sequentially transfer the photosensitive material to each tank for development, fixing, and washing, so that the contact area between each processing solution and air is large. Especially, the roller type automatic developing machine tends to have a large aperture ratio. Here, the opening ratio is a value obtained by dividing the contact area cm 2 between the processing liquid and the air in the processing liquid tank portion by the processing liquid amount cm 3 in the processing liquid tank. The aperture ratio of currently used automatic developing machines is generally 0.05 to 0.15.
As described above, so-called deterioration over time due to oxygen oxidation of the developer component such as the developing agent due to oxygen in the air due to the large aperture ratio, and so-called process fatigue due to consumption of the developer or fixer due to the processing of the photosensitive material are caused. A processing solution or a replenishing solution is supplied into the processing tank for recovery.
【0005】従来、感光材料の単位面積当りの必要補充
量は例えばX−レイ写真やグラフィックアーツ用感光材
料のようないわゆるシート状の写真感光材料1m2 に対
して300ml以上補充することが一般的であった。し
かし、写真用現像廃液特にハイドロキノンを現像主薬と
する写真用現像廃液は高い化学的酸素要求量(いわゆる
C.O.D)又は生物的酸素要求量(いわゆるB.O.
D)を有しているため、現像廃液に化学的又は生物的な
処理を施して無害化してから廃液にすることが行われて
いる。これらの廃液処理には多大な経済的負担がかか
る。Conventionally, the replenishment amount required per unit area of the light-sensitive material is generally 300 ml or more per 1 m 2 of a so-called sheet-shaped light-sensitive material such as a light-sensitive material for X-ray photography and graphic arts. there were. However, photographic developer wastes, especially photographic developer wastes containing hydroquinone as a developing agent, have high chemical oxygen demands (so-called COD) or biological oxygen demands (so-called BO).
Due to the fact that it has D), it is carried out that the developing waste liquid is chemically or biologically treated to render it harmless before being made into a waste liquid. A great economic burden is imposed on the treatment of these waste liquids.
【0006】しかしながら、感光材料の単位面積当りの
必要補充量の低減は廃液処理にかかる経済的負担を軽く
するが、処理タンク内に処理液が滞留する時間が長くな
り、特に現像タンクにおいては感光材料から溶出した銀
が析出し、処理タンク及びローラーを汚して、感光材料
を処理した際に画像を汚染する懸念がある。However, the reduction of the replenishment amount required per unit area of the light-sensitive material reduces the economical burden on the waste liquid treatment, but the treatment liquid stays in the treatment tank for a long period of time, especially in the developing tank. There is a concern that silver eluted from the material may be deposited, stain the processing tank and the roller, and contaminate the image when the photosensitive material is processed.
【0007】[0007]
【発明が解決しようとする課題】本発明の第1の目的
は、ハイドロキノン現像主薬の配合を必要としない現像
液組成物での現像処理方法を提供することにある。本発
明の第2の目的は、感光材料の単位面積当たり少ない補
充量で現像処理する方法を提供することにある。本発明
の第3の目的は、自現機の処理タンク及びローラーの銀
汚れを防止した現像処理方法を提供することにある。SUMMARY OF THE INVENTION A first object of the present invention is to provide a development processing method with a developer composition which does not require the incorporation of a hydroquinone developing agent. It is a second object of the present invention to provide a method of developing with a small replenishing amount per unit area of a light-sensitive material. A third object of the present invention is to provide a development processing method which prevents silver stains on the processing tank and rollers of the developing machine.
【0008】[0008]
【課題を解決するための手段】本発明における上記目的
は下記(1)〜(3)によって達成された。 (1)ハロゲン化銀写真感光材料を現像処理する方法に
おいて、該現像液中にハイドロキノンモノスルフォネー
トもしくはその誘導体と超加成性を示す補助現像主薬を
含有することを特徴とするハロゲン化銀写真感光材料の
処理方法。The above objects of the present invention have been achieved by the following items (1) to (3). (1) A method for developing a silver halide photographic light-sensitive material, characterized in that the developing solution contains an auxiliary developing agent which exhibits superadditivity with hydroquinone monosulfonate or its derivative. Processing method of photographic light-sensitive material.
【0009】(2)該現像液中に下記一般式(I)及び
/又は(II)で表される化合物を含有することを特徴と
する(1)記載のハロゲン化銀写真感光材料の処理方
法。 一般式(I)(2) The method for processing a silver halide photographic light-sensitive material described in (1), wherein the developer contains a compound represented by the following general formula (I) and / or (II). . General formula (I)
【0010】[0010]
【化3】 Embedded image
【0011】一般式(II)General formula (II)
【0012】[0012]
【化4】 [Chemical 4]
【0013】式中、R4 及びR5 はそれぞれ水素原子、
炭素数1〜3のアルキル基又はフェニル基を表し、R6
及びR7 はそれぞれ水素原子又は炭素数1〜3のアルキ
ル基を表す。m及びnはそれぞれ0、1又は2である。
R8 はヒドロキシル基、アミノ基又は炭素数1〜3のア
ルキル基を表す。R9 はR8 で表される基又は水素原子
を表わす。Mは水素原子、アルカリ金属原子又はアンモ
ニウム基を表す。Xは、水素原子、炭素数1〜3のアル
キル基、スルホニル基、アミノ基、アシル基又はアルコ
キシカルボニル基を表す。In the formula, R 4 and R 5 are each a hydrogen atom,
Represents an alkyl group having 1 to 3 carbon atoms or a phenyl group, R 6
And R 7 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms. m and n are 0, 1 or 2.
R 8 represents a hydroxyl group, an amino group or an alkyl group having 1 to 3 carbon atoms. R 9 represents a group represented by R 8 or a hydrogen atom. M represents a hydrogen atom, an alkali metal atom or an ammonium group. X represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a sulfonyl group, an amino group, an acyl group or an alkoxycarbonyl group.
【0014】(3)該現像液の補充量がハロゲン化銀写
真感光材料1m2 当たり25ml以上200ml以下で
あることを特徴とする上記(1)又は(2)記載のハロ
ゲン化銀写真感光材料の処理方法。(3) The silver halide photographic light-sensitive material as described in (1) or (2) above, wherein the replenishing amount of the developing solution is 25 ml or more and 200 ml or less per 1 m 2 of the silver halide photographic light-sensitive material. Processing method.
【0015】以下に本発明をさらに詳しく説明する。は
じめに、本発明の現像液中に現像主薬として含有される
ハイドロキノンモノスルフォネートもしくはその誘導体
について説明する。本発明の現像液中に現像主薬として
含有されるハイドロキノンモノスルフォネートもしくは
その誘導体は好ましくは下記一般式(III )で表される
化合物である。 一般式(III)The present invention will be described in more detail below. First, the hydroquinone monosulfonate or its derivative contained as a developing agent in the developer of the present invention will be described. The hydroquinone monosulfonate or its derivative contained as a developing agent in the developer of the present invention is preferably a compound represented by the following general formula (III). General formula (III)
【0016】[0016]
【化5】 Embedded image
【0017】式中、R1 、R2 及びR3 はそれぞれ水素
原子、アルキル基、アリール基、アルキルチオ基、ヘテ
ロ環基、アリールチオ基、アルコキシ基、アリールオキ
シ基、アミノ基、カルボンアミド基、スルホンアミド
基、アルコキシカルボニルアミノ基、ウレイド基、カル
バモイル基、アルコキシカルボニル基、スルファモイル
基、スルホニル基、シアノ基、ハロゲン原子、アシル
基、カルボキシ基、スルホ基又はニトロ基を表す。尚、
R1 とR2 が結合して環を形成してもよい。M+ は水素
イオンもしくは一価又は多価の対イオンである。R1 及
びR2 として好ましくは水素原子、アルキルチオ基、ア
ルコキシ基、アリールオキシ基、アミド基、スルホンア
ミド基、アルコキシカルボニルアミノ基又はウレイド基
であり、さらに好ましくは水素原子、アルキルチオ基、
アルコキシ基、カルボンアミド基、スルホンアミド基、
アルコキシカルボニルアミノ基又はウレイド基である。
R1 とR2 は結合して環を形成してもよい。In the formula, R 1 , R 2 and R 3 are each a hydrogen atom, an alkyl group, an aryl group, an alkylthio group, a heterocyclic group, an arylthio group, an alkoxy group, an aryloxy group, an amino group, a carbonamido group and a sulfone. It represents an amide group, an alkoxycarbonylamino group, a ureido group, a carbamoyl group, an alkoxycarbonyl group, a sulfamoyl group, a sulfonyl group, a cyano group, a halogen atom, an acyl group, a carboxy group, a sulfo group or a nitro group. still,
R 1 and R 2 may combine to form a ring. M + is a hydrogen ion or a monovalent or polyvalent counterion. R 1 and R 2 are preferably a hydrogen atom, an alkylthio group, an alkoxy group, an aryloxy group, an amide group, a sulfonamide group, an alkoxycarbonylamino group or a ureido group, more preferably a hydrogen atom, an alkylthio group,
Alkoxy group, carbonamide group, sulfonamide group,
It is an alkoxycarbonylamino group or an ureido group.
R 1 and R 2 may combine to form a ring.
【0018】R3 として好ましくは水素原子、カルバモ
イル基、アルコキシカルボニル基、スルファモイル基、
スルホニル基、シアノ基、アシル基、ヘテロ環基であ
り、更に好ましくは水素原子、カルバモイル基、アルコ
キシカルボニル基、スルファモイル基、シアノ基であ
る。以下に本発明のハイドロキノンモノスルフォネート
もしくはその誘導体の具体例を挙げるが、本発明はこれ
らに限定されるものではない。R 3 is preferably a hydrogen atom, a carbamoyl group, an alkoxycarbonyl group, a sulfamoyl group,
It is a sulfonyl group, a cyano group, an acyl group or a heterocyclic group, more preferably a hydrogen atom, a carbamoyl group, an alkoxycarbonyl group, a sulfamoyl group or a cyano group. Specific examples of the hydroquinone monosulfonate or its derivative of the present invention are shown below, but the present invention is not limited thereto.
【0019】[0019]
【化6】 [Chemical 6]
【0020】[0020]
【化7】 [Chemical 7]
【0021】[0021]
【化8】 Embedded image
【0022】[0022]
【化9】 [Chemical 9]
【0023】次に、本発明の超加成性を示す補助現像主
薬について説明する。超加成性を示す補助現像主薬とし
ては1−フェニル−3−ピラゾリドン類補助現像主薬あ
るいはp−アミノフェーノール類補助現像主薬がある。
1−フェニル−3−ピラゾリドン類補助現像主薬として
は1−フェニル−3−ピラゾリドン、1−フェニル−
4,4−ジメチル−3−ピラゾリドン、1−フェニル−
4−メチル−4−ヒドロキシメチル−3−ピラゾリド
ン、1−フェニル−4,4−ジヒドロキシメチル−3−
ピラゾリドン、1−フェニル−5−メチル−3−ピラゾ
リドン、1−p−アミノフェニル−4,4−ジメチル−
3−ピラゾリドン、1−p−トリル−4,4−ジメチル
−3−ピラゾリドン、1−p−トリル−4−メチル−4
−ヒドロキシメチル−3−ピラゾリドンなどがある。こ
れらのうち1−フェニル−3−ピラゾリドン又は1−フ
ェニル−4−メチル−4−ヒドロキシメチル−3−ピラ
ゾリドンが好ましい。Next, the auxiliary developing agent exhibiting superadditivity of the present invention will be described. Examples of the auxiliary developing agent exhibiting superadditivity include 1-phenyl-3-pyrazolidones auxiliary developing agents and p-aminophenols auxiliary developing agents.
As 1-phenyl-3-pyrazolidones auxiliary developing agents, 1-phenyl-3-pyrazolidone and 1-phenyl-
4,4-dimethyl-3-pyrazolidone, 1-phenyl-
4-methyl-4-hydroxymethyl-3-pyrazolidone, 1-phenyl-4,4-dihydroxymethyl-3-
Pyrazolidone, 1-phenyl-5-methyl-3-pyrazolidone, 1-p-aminophenyl-4,4-dimethyl-
3-pyrazolidone, 1-p-tolyl-4,4-dimethyl-3-pyrazolidone, 1-p-tolyl-4-methyl-4
-Hydroxymethyl-3-pyrazolidone and the like. Of these, 1-phenyl-3-pyrazolidone or 1-phenyl-4-methyl-4-hydroxymethyl-3-pyrazolidone is preferable.
【0024】p−アミノフェーノール類補助現像主薬と
してはN−メチル−p−アミノフェノール、N−(β−
ヒドロキシエチル)−p−アミノフェノール、N−(4
−ヒドロキシフェニル)−グリシン、2−メチル−p−
アミノフェノール、p−ベンジルアミノフェノール等が
あるが、なかでもN−メチル−p−アミノフェーノール
が好ましい。P-aminophenols auxiliary developing agents include N-methyl-p-aminophenol and N- (β-
Hydroxyethyl) -p-aminophenol, N- (4
-Hydroxyphenyl) -glycine, 2-methyl-p-
There are aminophenol, p-benzylaminophenol and the like, and among them, N-methyl-p-aminophenol is preferable.
【0025】本発明のハイドロキノンモノスルフォネー
トもしくはその誘導体現像主薬とともに超加成性を示す
補助現像主薬の使用量は前者を0.01モル/リットル
〜0.6モル/リットル、後者を0.001モル/リッ
トル〜0.1モル/リットルの量で用いられるのが好ま
しく、特に後者を0.005モル/リットル〜0.06
モル/リットルの量で用いるのが好ましい。The amount of the auxiliary developing agent exhibiting superadditivity together with the developing agent of hydroquinone monosulfonate or its derivative of the present invention is 0.01 mol / liter to 0.6 mol / liter for the former and 0. It is preferably used in an amount of 001 mol / l to 0.1 mol / l, especially the latter of 0.005 mol / l to 0.06.
It is preferably used in an amount of mol / liter.
【0026】本発明の現像処理液は、ハイドロキノンを
実質的に含有しない。ここで、実質的に含有しないと
は、0.0001モル/リットル以下が望ましく、全く
含有しないことが最も好ましい。The development processing solution of the present invention contains substantially no hydroquinone. Here, the term "substantially free from" means preferably 0.0001 mol / liter or less, and most preferably free.
【0027】次に、本発明の現像処理液中に含有される
一般式(I)あるいは一般式(II)で表される化合物に
ついて説明する。 一般式(I)Next, the compound represented by the general formula (I) or the general formula (II) contained in the developing solution of the present invention will be described. General formula (I)
【0028】[0028]
【化10】 [Chemical 10]
【0029】一般式(II)General formula (II)
【0030】[0030]
【化11】 [Chemical 11]
【0031】式中、R4 及びR5 はそれぞれ水素原子、
炭素数1〜3のアルキル基(例えば、メチル、エチル、
i−プロピル)又はフェニル基を表し、R6 及びR7 は
それぞれ水素原子又は炭素数1〜3のアルキル基(例え
ば、メチル、エチル、i−プロピル)を表す。m及びn
はそれぞれ0、1又は2である。R8 はヒドロキシル
基、アミノ基〔例えば無置換アミノ、アシルアミノ基
(例えば、アセチルアミノ)、アルキルアミノ基(例え
ばジメチルアミノ)、アルキルスルホニルアミノ基(例
えば、メタンスルホニルアミノ)、アリールスルホニル
アミノ基(例えばフェニルスルホニルアミノ)〕又は炭
素数1〜3のアルキル基(例えば、メチル、エチル、i
−プロピル)を表す。R9 はR8 で表わされる基又は水
素原子を表わす。Mは水素原子、アルカリ金属原子又は
アンモニウム基を表す。Xは、水素原子、炭素数1〜3
のアルキル基(例えば、メチル、エチル、i−プロピ
ル)、スルホニル基(例えば、メタンスルホニル)、ア
ミノ基〔例えば無置換アミノ、アシルアミノ基(例え
ば、アセチルアミノ)、アルキルアミノ基(例えばジメ
チルアミノ)、アルキルスルホニルアミノ基(例えば、
メタンスルホニルアミノ)、アリールスルホニルアミノ
基(例えばフェニルスルホニルアミノ)〕、アシル基
(例えばアセチル、プロピオニル)又はアルコキシカル
ボニル基(例えばアセトキシ、メトキシカルボニル、エ
トキシカルボニル)を表す。In the formula, R 4 and R 5 are each a hydrogen atom,
An alkyl group having 1 to 3 carbon atoms (for example, methyl, ethyl,
i-propyl) or a phenyl group, and R 6 and R 7 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms (eg, methyl, ethyl, i-propyl). m and n
Are 0, 1 or 2, respectively. R 8 is a hydroxyl group, an amino group [eg, unsubstituted amino, acylamino group (eg, acetylamino), alkylamino group (eg, dimethylamino), alkylsulfonylamino group (eg, methanesulfonylamino), arylsulfonylamino group (eg, Phenylsulfonylamino)] or an alkyl group having 1 to 3 carbon atoms (for example, methyl, ethyl, i
-Propyl). R 9 represents a group represented by R 8 or a hydrogen atom. M represents a hydrogen atom, an alkali metal atom or an ammonium group. X is a hydrogen atom and has 1 to 3 carbon atoms
Alkyl group (for example, methyl, ethyl, i-propyl), sulfonyl group (for example, methanesulfonyl), amino group [for example, unsubstituted amino, acylamino group (for example, acetylamino), alkylamino group (for example, dimethylamino), An alkylsulfonylamino group (for example,
Methanesulfonylamino), an arylsulfonylamino group (eg phenylsulfonylamino)], an acyl group (eg acetyl, propionyl) or an alkoxycarbonyl group (eg acetoxy, methoxycarbonyl, ethoxycarbonyl).
【0032】本発明の一般式(I)又は(II)の化合物
の現像処理液中における好ましい濃度は0.01ミリモ
ル/リットル〜50ミリモル/リットルであり、さらに
好ましくは0.05ミリモル/リットル〜10ミリモル
/リットルであり、特に好ましくは0.1ミリモル/リ
ットル〜5ミリモル/リットルである。The concentration of the compound of the general formula (I) or (II) of the present invention in the developing solution is preferably 0.01 mmol / liter to 50 mmol / liter, more preferably 0.05 mmol / liter to It is 10 mmol / liter, particularly preferably 0.1 mmol / liter to 5 mmol / liter.
【0033】本発明の処理方法は自動現像機を用いた処
理で有効であり、本発明の一般式(I)又は(II)の化
合物を現像処理液中に上記の濃度で存在することによっ
て、自動現像機の現像処理タンク及びローラーの銀汚れ
を防止できる。The processing method of the present invention is effective for the processing using an automatic processor, and the presence of the compound of the general formula (I) or (II) of the present invention in the developing solution at the above concentration It is possible to prevent silver stains on the development processing tank and rollers of the automatic processor.
【0034】以下に本発明に用いることができる一般式
(I)又は一般式(II)で表される化合物の具体例を示
すが、本発明はこれらに限定されるものではない。Specific examples of the compound represented by formula (I) or formula (II) that can be used in the present invention are shown below, but the present invention is not limited thereto.
【0035】[0035]
【化12】 [Chemical 12]
【0036】[0036]
【化13】 [Chemical 13]
【0037】[0037]
【化14】 Embedded image
【0038】本発明に用いる現像液には現像促進のため
にアミノ化合物を含有してもよい。特に特開昭56−1
06244号、特開昭61−267759号、特開平2
−208652に記載のアミノ化合物を用いてもよい。
本発明に用いる現像液のpHは8.0〜13.0であ
り、好ましくは9.0〜12.5であり、さらに好まし
くは10.0〜12.0である。The developer used in the present invention may contain an amino compound for promoting development. In particular, JP-A-56-1
06244, JP-A-61-267759, JP-A-2
The amino compound described in -208652 may be used.
The pH of the developer used in the present invention is 8.0 to 13.0, preferably 9.0 to 12.5, and more preferably 10.0 to 12.0.
【0039】本発明に用いられる現像液のpHの設定の
ために用いるアルカリ剤には通常の水溶性無機アルカリ
金属塩(例えば、水酸化ナトリウム、炭酸ナトリウム)
を用いることができる。本発明の現像液にはその他、第
二燐酸ナトリウム、第二燐酸カリウム、第一燐酸ナトリ
ウム、第一燐酸カリウムの如きpH緩衝剤を、それ以外
に特開昭60−93433号に記載のpH緩衝剤を用い
ることができる。本発明の現像液のpH値設定のために
用いられるアルカリ剤やpH緩衝剤の添加量は0.01
モル/リットル以上1.8モル/リットルが好ましく、
特に0.1モル/リットル以上1モル/リットル以下が
好ましい。The alkaline agent used for setting the pH of the developing solution used in the present invention is a usual water-soluble inorganic alkali metal salt (eg sodium hydroxide, sodium carbonate).
Can be used. The developer of the present invention may further contain a pH buffering agent such as dibasic sodium phosphate, dibasic potassium phosphate, monobasic sodium phosphate and monobasic potassium phosphate, and a pH buffering agent described in JP-A-60-93433. Agents can be used. The addition amount of the alkaline agent or the pH buffering agent used for setting the pH value of the developing solution of the present invention is 0.01
Mol / l or more and preferably 1.8 mol / l,
Particularly, it is preferably 0.1 mol / liter or more and 1 mol / liter or less.
【0040】本発明の現像液に用いることのできる亜硫
酸塩系の保恒剤としては亜硫酸ナトリウム、亜硫酸カリ
ウム、亜硫酸リチウム、亜硫酸アンモニウム、重亜硫酸
ナトリウム、メタ重亜硫酸カリウムなどがある。亜硫酸
塩は0.01モル/リットル以上、特に0.02モル/
リットル以上、2.5モル/リットル以下で用いること
が好ましい。本発明の現像液は上記亜硫酸塩保恒剤の他
にアスコルビン酸又は/及びその誘導体を含んでもよ
い。好ましくはアスコルビン酸又はエリソルビン酸(ア
スコルビン酸のジアステレオマー)である。アスコルビ
ン酸又は/及びその誘導体の使用量の一般的な範囲とし
ては5×10-3モル/リットル〜1モル/リットルであ
り、特に好ましくは5×10-2モル/リットル〜0.5
モル/リットルである。この他、L.F.A.メイスン
著「フォトグラフィック・プロセッシング・ケミストリ
ー」フォーカル・プレス刊(1966年)の226〜2
29項、米国特許第2,193,015号、米国特許
2,592,364号、特開昭48−64933号など
に記載のものを用いてもよい。Examples of sulfite-based preservatives that can be used in the developer of the present invention include sodium sulfite, potassium sulfite, lithium sulfite, ammonium sulfite, sodium bisulfite, and potassium metabisulfite. Sulfite is 0.01 mol / liter or more, especially 0.02 mol / liter
It is preferably used in an amount of liter or more and 2.5 mol / liter or less. The developer of the present invention may contain ascorbic acid or / and a derivative thereof in addition to the sulfite preservative. Preferred is ascorbic acid or erythorbic acid (a diastereomer of ascorbic acid). The amount of ascorbic acid or / and its derivative used is generally in the range of 5 × 10 −3 mol / liter to 1 mol / liter, particularly preferably 5 × 10 −2 mol / liter to 0.5.
Mol / liter. In addition, L. F. A. Mason's "Photographic Processing Chemistry" published by Focal Press (1966) 226-2
29, US Pat. No. 2,193,015, US Pat. No. 2,592,364, and JP-A-48-64933 may be used.
【0041】本発明に用いられる現像液には上記ような
アミノ化合物やアルカリ剤の他に臭化カリウム、沃化カ
リウムの如き現像抑制剤、ジメチルホルムアミド、メチ
スセルソルブ、エチレングリコール、エタノール、メタ
ノールの如き有機溶剤、5−メチルベンツトリアゾー
ル、5−クロルベンツトリアゾール、5−ブロムベンツ
トリアゾール、5−ブチルベンツトリアゾール、ベンツ
トリアゾール等の如きかぶり防止剤を添加してもよい。In the developer used in the present invention, in addition to the above amino compounds and alkali agents, development inhibitors such as potassium bromide and potassium iodide, organic compounds such as dimethylformamide, methyscellosolve, ethylene glycol, ethanol and methanol. An antifoggant such as a solvent, 5-methylbenztriazole, 5-chlorobenztriazole, 5-bromobenztriazole, 5-butylbenztriazole or benztriazole may be added.
【0042】更に必要に応じて色調剤、界面活性剤、硬
水軟化剤、硬膜剤などを含んでもよい。現像液中のキレ
ート剤としては、エチレンジアミンジオルトヒドロキシ
フェニル酢酸、ジアミノプロパン四酢酸、ニトリロ三酢
酸、ヒドロキシエチルエチレンジアミン三酢酸、ジヒド
ロキシエチルグリシン、エチレンジアミン二酢酸、エチ
レンジアミン二プロピオン酸、イミノ二酢酸、ジエチレ
ントリアミン五酢酸、ヒドロキシエチルイミノ二酢酸、
1,3−ジアミノプロパノール四酢酸、トリエチレンテ
トラミン六酢酸、トランスシクロヘキサンジアミン四酢
酸、エチレンジアミン四酢酸、グリコールエーテルジア
ミン四酢酸、エチレンジアミンテトラキスメチレンホス
ホン酸、ジエチレントリアミンペンタメチレンホスホン
酸、ニトリロトリメチレンホスホン酸、1−ヒドロキシ
エチリデン−1,1−ジホスホン酸、1,1−ジホスホ
ノエタン−2−カルボン酸、2−ホスホノブタン−1,
2,4−トリカルボン酸、1−ヒドロキシ−1−ホスホ
ノプロパン−1,3,3−トリカルボン酸、カテコール
−3,4−ジスルホン酸、ピロリン酸ナトリウム、テト
ラポリリン酸ナトリウム、ヘキサメタリン酸ナトリウム
等が挙げられるが、特に好ましくはジエチレントリアミ
ン五酢酸、トリエチレンテトラミン六酢酸、1,3−ジ
アミノプロパノール四酢酸、グリコールエーテルジアミ
ン四酢酸、ヒドロキシエチルエチレンジアミン三酢酸、
2−ホスホノブタン−1,2,4−トリカルボン酸、
1,1−ジホスホノエタン−2−カルボン酸、ニトリロ
トリメチレンホスホン酸、エチレンジアミンテトラキス
メチレンホスホン酸、ジエチレントリアミンペンタホス
ホン酸、1−ヒドロキシプロピリデン−1,1−ジホス
ホン酸、1−アミノエチリデン−1,1−ジホスホン
酸、1−ヒドロキシエチリデン−1,1−ジホスホン酸
やこれらの塩がある。If necessary, a toning agent, a surfactant, a water softener, a hardener, etc. may be added. As the chelating agent in the developing solution, ethylenediaminedioltohydroxyphenylacetic acid, diaminopropanetetraacetic acid, nitrilotriacetic acid, hydroxyethylethylenediaminetriacetic acid, dihydroxyethylglycine, ethylenediaminediacetic acid, ethylenediaminedipropionic acid, iminodiacetic acid, diethylenetriaminepentaacetic acid. Acetic acid, hydroxyethyliminodiacetic acid,
1,3-diaminopropanoltetraacetic acid, triethylenetetraminehexaacetic acid, transcyclohexanediaminetetraacetic acid, ethylenediaminetetraacetic acid, glycoletherdiaminetetraacetic acid, ethylenediaminetetrakismethylenephosphonic acid, diethylenetriaminepentamethylenephosphonic acid, nitrilotrimethylenephosphonic acid, 1- Hydroxyethylidene-1,1-diphosphonic acid, 1,1-diphosphonoethane-2-carboxylic acid, 2-phosphonobutane-1,
2,4-tricarboxylic acid, 1-hydroxy-1-phosphonopropane-1,3,3-tricarboxylic acid, catechol-3,4-disulfonic acid, sodium pyrophosphate, sodium tetrapolyphosphate, sodium hexametaphosphate and the like can be mentioned. However, particularly preferably diethylenetriaminepentaacetic acid, triethylenetetraminehexaacetic acid, 1,3-diaminopropanoltetraacetic acid, glycol etherdiaminetetraacetic acid, hydroxyethylethylenediaminetriacetic acid,
2-phosphonobutane-1,2,4-tricarboxylic acid,
1,1-diphosphonoethane-2-carboxylic acid, nitrilotrimethylenephosphonic acid, ethylenediaminetetrakismethylenephosphonic acid, diethylenetriaminepentaphosphonic acid, 1-hydroxypropylidene-1,1-diphosphonic acid, 1-aminoethylidene-1,1-diphosphonone Acid, 1-hydroxyethylidene-1,1-diphosphonic acid and salts thereof.
【0043】本発明の現像液は輸送費低減や貯蔵スペー
スの削減のために濃縮液とすることもできる。濃縮液と
する場合には低温時の現像液成分の析出防止する目的で
3倍以下とすることが好ましく、さらに2倍以下がより
好ましい。また、溶解度の異なる成分をいくつかのパー
トに分けて保存し、使用時に混合、希釈して用いてもよ
い。The developing solution of the present invention can be used as a concentrated solution in order to reduce transportation costs and storage space. In the case of using a concentrated solution, it is preferably 3 times or less, more preferably 2 times or less, for the purpose of preventing precipitation of the developer component at a low temperature. Further, components having different solubilities may be divided into some parts and stored, and may be mixed and diluted before use.
【0044】本発明の現像液の補充量は希釈現像液とし
て感光材料1m2 当たり200ml以下25ml以上で
あり、好ましくは180ml以下30ml以上であり、
更に好ましくは150ml以下60ml以上である。The replenishing amount of the developer of the present invention is 200 ml or less and 25 ml or more, preferably 180 ml or less and 30 ml or more per 1 m 2 of the light-sensitive material as a diluted developer.
More preferably, it is 150 ml or less and 60 ml or more.
【0045】本発明の処理において、現像処理された感
光材料は定着処理が行なわれる。次に本発明の処理にお
ける定着液について説明する。本発明の処理における定
着液には通常用いられる定着剤として、例えばチオ硫酸
ナトリウム、チオ硫酸アンモニウム等のチオ硫酸塩を含
有するが、環境問題上チオ硫酸ナトリウムを用いること
が好ましい。本発明の処理における定着液に含有される
チオ硫酸塩の含有量は、0.1モル/リットル以上3モ
ル/リットル以下であり、好ましくは0.3モル/リッ
トル以上1.5モル/リットル以下である。In the processing of the present invention, the photosensitive material which has undergone the development processing is subjected to the fixing processing. Next, the fixing solution in the processing of the present invention will be described. The fixing solution in the processing of the present invention contains a thiosulfate such as sodium thiosulfate and ammonium thiosulfate as a commonly used fixing agent, but sodium thiosulfate is preferably used in view of environmental problems. The content of the thiosulfate contained in the fixing solution in the processing of the present invention is 0.1 mol / liter or more and 3 mol / liter or less, preferably 0.3 mol / liter or more and 1.5 mol / liter or less. Is.
【0046】定着液には所望により、硬膜剤(例えば塩
化アルミニウム、硫酸アルミニウム、カリ明ばん等の水
溶性アルミニウム)、保恒剤(例えば亜硫酸塩、重亜硫
酸塩等)、pH緩衝剤(例えば酢酸、硼酸等)、pH調
整剤(例えばアンモニア、硫酸等)、キレート剤、界面
活性剤(例えばスルホン化物などのアニオン性界面活性
剤、ポリエチレン系界面活性剤、特開昭57−6804
号に記載の両性界面活性剤等)、湿潤剤(例えばアルカ
ノールアミン、アルキレングリコール等)、定着促進剤
(例えば特公昭45−35754号、特公昭58−12
2535号、特公昭58−122536号に記載のチオ
尿素誘導体、分子内に三重結合を持つアルコール、米国
特許4126459号記載のチオエーテル化合物、特開
平4−143755号、特開平4−143756号、特
開平4−143757号、特開平4−170539等に
記載のメソイオン化合物等)を含むことができる。If desired, the fixing solution may include a hardening agent (eg, aluminum chloride, aluminum sulfate, water-soluble aluminum such as potassium alum), a preservative (eg, sulfite, bisulfite, etc.), and a pH buffer (eg, Acetic acid, boric acid, etc., pH adjusters (eg, ammonia, sulfuric acid, etc.), chelating agents, surfactants (eg, anionic surfactants such as sulfonates, polyethylene type surfactants, JP-A-57-6804).
Amphoteric surfactants, etc.), wetting agents (eg alkanolamines, alkylene glycols, etc.), fixing accelerators (eg JP-B-45-35754, JP-B-58-12).
No. 2535, Japanese Patent Publication No. 58-122536, thiourea derivatives, alcohols having a triple bond in the molecule, thioether compounds described in US Pat. No. 4,126,459, JP-A-4-143755, JP-A-4-143756, JP-A-4-143756. 4-143757, mesoionic compounds described in JP-A-4-170539 and the like) can be included.
【0047】本発明の処理における定着液には上記化合
物以外に酒石酸、クエン酸、グルコン酸あるいはそれら
の誘導体を単独であるいは二種以上用いることができ
る。本発明の処理における定着液はpH3以上であり、
好ましくは4.2〜6.3である。本発明の処理におけ
る定着処理における定着処理温度及び定着処理時間は約
20℃〜50℃で5秒から1分が好ましい。In the fixing solution in the processing of the present invention, tartaric acid, citric acid, gluconic acid or their derivatives may be used alone or in combination of two or more in addition to the above compounds. The fixer used in the process of the present invention has a pH of 3 or higher,
It is preferably 4.2 to 6.3. The fixing processing temperature and the fixing processing time in the fixing processing in the processing of the present invention are preferably about 20 ° C. to 50 ° C. and 5 seconds to 1 minute.
【0048】本発明の処理における定着液は輸送費低減
や貯蔵スペースの削減のために濃縮液とすることもでき
る。濃縮液とする場合には低温時の定着液成分の析出防
止する目的で3倍以下とすることが好ましく、さらに2
倍以下がより好ましい。また、溶解度の異なる成分をい
くつかのパートに分けて保存し、使用時に混合、希釈し
て用いてもよい。The fixing solution used in the process of the present invention can be a concentrated solution in order to reduce transportation costs and storage space. In the case of using a concentrated solution, it is preferably 3 times or less for the purpose of preventing precipitation of the fixer component at low temperature, and further 2
It is more preferably equal to or less than twice. Further, components having different solubilities may be divided into some parts and stored, and may be mixed and diluted before use.
【0049】本発明の処理における定着液の補充量は希
釈定着液として感光材料1m2 当たり200ml以下2
5ml以上であり、好ましくは180ml以下30ml
以上であり、更に好ましくは150ml以下60ml以
上である。In the processing of the present invention, the replenishing amount of the fixing solution is 200 ml or less per 1 m 2 of the light-sensitive material as a diluted fixing solution.
5 ml or more, preferably 180 ml or less 30 ml
It is above, and more preferably 150 ml or less and 60 ml or more.
【0050】本発明において現像液及び定着液の供給が
濃縮現像液及び濃縮定着液である場合には使用液に希釈
して補充液又は母液として用いられる。希釈する方法と
しては、予め希釈された希釈現像液及び希釈定着液をそ
れぞれ現像タンク及び定着タンクに添加してもよいが、
濃縮現像液及び濃縮定着液の各液と水とが各タンク内で
使用液に希釈されて、補充液として供給される(直接混
合希釈方式)ことが好ましい。自現機にケミカルミキサ
ーを内蔵する際、現像液と定着液のカートリッジが同時
に使い終わる機構を有する自現機であることが好まし
い。In the present invention, when the supply of the developing solution and the fixing solution is the concentrated developing solution and the concentrated fixing solution, they are diluted with the used solution and used as a replenishing solution or a mother solution. As a method of diluting, a prediluted diluted developing solution and diluted fixing solution may be added to the developing tank and the fixing tank, respectively.
It is preferable that each of the concentrated developing solution and the concentrated fixing solution and water are diluted into a working solution in each tank and supplied as a replenishing solution (direct mixing dilution system). When the chemical mixer is incorporated in the automatic developing machine, it is preferable that the automatic developing machine has a mechanism in which the cartridges of the developing solution and the fixing solution are used up at the same time.
【0051】本発明における処理方法では、現像、定着
工程の後に水洗水又は安定化液で処理され、ついで乾燥
される。本発明に使用する水洗水は、水洗層に供給する
前に前処理としてフィルター部材又は活性炭のフィルタ
ーを通して水中に存在するごみや有機物質を除去すると
好ましいことがある。In the processing method of the present invention, after the development and fixing steps, the solution is treated with washing water or a stabilizing solution and then dried. The washing water used in the present invention may be preferably pretreated by removing dust and organic substances existing in water through a filter member or a filter of activated carbon as a pretreatment.
【0052】防ばい手段として知られている特開昭60
−263939号に記載された紫外線照射法、特開昭6
0−263940号に記載された磁場を用いる方法、特
開昭61−131632号に記載されたイオン交換樹脂
を用いて純水にする方法、特開平4−151143号に
記載されたオゾンを吹き込みながらフィルター及び吸着
剤カラムを循環する方法、特開平4−240636号に
記載された微生物分解による方法、特開昭62−115
154号、特開昭62−153952号、特開昭62−
220951、特開昭62−209532号に記載の防
菌剤を用いる方法を併用することができる。Japanese Unexamined Patent Publication No. Sho 60, which is known as an anti-fungal means.
UV irradiation method described in US Pat.
No. 0-263940, the method using a magnetic field, the method described in JP-A No. 61-131632 to make pure water using an ion exchange resin, and the ozone described in JP-A No. 4-151143 while blowing ozone. A method of circulating a filter and an adsorbent column, a method of microbial decomposition described in JP-A-4-240636, and JP-A-62-115.
154, JP-A-62-153952, JP-A-62-1952
220951 and the method using a bacteriostatic agent described in JP-A No. 62-209532 can be used in combination.
【0053】さらには、M.W.Beach,“Mic
robiological Groths in Mo
tion−picture Processing”
SMPTE Journal Vol.85(197
6)、R.O.Deegan,“Photo Proc
essing Wash Water Biocade
s”J.Imaging Tech. Vol.10,
No.6(1984)及び特開昭57−8542号、特
開昭57−58143号、特開昭58−105145
号、特開昭57−132146号、特開昭58−186
31号、特開昭57−97530号、特開昭57−25
7244号などに記載されている防菌剤、防ばい剤、界
面活性剤などを必要に応じて併用することもできる。Furthermore, M. W. Each, "Mic
robotic Groths in Mo
"tion-picture Processing"
SMPTE Journal Vol. 85 (197
6), R. O. Deegan, “Photo Proc
essing Wash Water Biocade
s "J. Imaging Tech. Vol. 10,
No. 6 (1984) and JP-A-57-8542, JP-A-57-58143, and JP-A-58-105145.
JP-A-57-132146, JP-A-58-186
31, JP-A-57-97530, JP-A-57-25
Antibacterial agents, antifungal agents, surfactants and the like described in 7244 can be used in combination as necessary.
【0054】さらに、水洗浴(あるいは安定化浴)には
必要に応じ、R.T.Kreiman著、J.Imag
e.Tech. Vol.10,No.6,242項
(1984)に記載されたイソチアゾリン系化合物や、
ブロモクロロジメチルヒダントイン、Research
Disclosure第205巻、No.20526
(1981年、5月号)、Research Disc
losure第228巻、No.22845(1983
年、4月号)に記載されたイソチアゾリン系化合物、特
開昭62−209532号に記載された化合物などを防
菌剤として併用することもできる。If necessary, the washing bath (or stabilizing bath) may be R. T. Kreiman, J. Image
e. Tech. Vol. 10, No. The isothiazoline compounds described in 6,242 (1984),
Bromochlorodimethylhydantoin, Research
Disclosure Volume 205, No. 20526
(May 1981, May issue), Research Disc
Loss Volume 228, No. 22845 (1983
The isothiazoline-based compounds described in JP-A-62-209532 and the like can be used in combination as a bacteriostatic agent.
【0055】その他、「防菌防ばいの科学」堀口博著、
三井出版(昭和57年)、「防菌防ばい技術ハンドブッ
ク」日本防菌防ばい学会・博報堂(昭和61年)に記載
されているような化合物を含んでもよい。本発明で用い
ることができる自現機には水洗タンクの水垢防止策とし
て、水洗タンクの排水口に電磁弁が設置された自現機を
用いることが好ましい。In addition, Hiroshi Horiguchi, "Science and Antibacterial Science",
Compounds such as those described in Mitsui Shuppan (1982), "Handbook of Antibacterial and Antibacterial Technology", Japan Society for Antibacterial and Antibacterial Agent, Hakuhodo (1986) may be included. As the automatic developing machine that can be used in the present invention, it is preferable to use an automatic developing machine in which a solenoid valve is installed at the drain port of the washing tank as a measure for preventing water stains on the washing tank.
【0056】現像、定着、水洗(ないし安定化)された
感材はは水洗水をしぼり切る、すなわちスクイズローラ
ーを経て乾燥される。乾燥は約40℃〜約100℃で行
われ、乾燥時間は周囲の状態によって適宜変えられる
が、通常は約5秒〜3分でよく、特に好ましくは40〜
80℃で約5秒〜2分である。The photosensitive material which has been developed, fixed and washed (or stabilized) is squeezed out of the washing water, that is, dried through a squeeze roller. The drying is carried out at about 40 ° C. to about 100 ° C., and the drying time is appropriately changed depending on the ambient conditions, but it is usually about 5 seconds to 3 minutes, particularly preferably 40 to
It is about 5 seconds to 2 minutes at 80 degreeC.
【0057】本発明に用いられる自現機としてはローラ
ー搬送型、ベルト搬送型等種々の形式の自現機を用いる
ことができるが、ローラー搬送型の自現機が好ましい。
また、特開平1−193853号に記載のような開口率
の小さい現像タンクの自現機が好ましく、開口率は0.
04以下0.01以上が好ましく、さらに開口率0.0
3以下0.01以上が好ましく、特に開口率0.025
以下0.01以上の現像タンクを有する自現機が最も好
ましい。このことにより、現像主薬等の空気酸化や水の
蒸発が少なく、補充量を低減できる。処理環境下では水
洗水をしぼり切る、すなわちスクイズローラーを経て乾
燥される。乾燥は約40℃〜約100℃で行われ、乾燥
時間は周囲の状態によって適宜変えられるが、通常は約
5秒〜3分でよく、特に好ましくは40〜80℃で約5
秒〜2分である。As the automatic developing machine used in the present invention, various types of automatic developing machines such as a roller carrying type and a belt carrying type can be used, but a roller carrying type developing machine is preferable.
Further, a developing machine of a developing tank having a small opening ratio as described in JP-A No. 1-193853 is preferable, and the opening ratio is 0.1.
04 or less and 0.01 or more are preferable, and the aperture ratio is 0.0
3 or less and 0.01 or more are preferable, and especially the aperture ratio is 0.025.
The most preferable is an automatic developing machine having a developing tank of 0.01 or more. As a result, air oxidation of the developing agent and the like and evaporation of water are small, and the replenishment amount can be reduced. Under the processing environment, the washing water is squeezed out, that is, dried through a squeeze roller. Drying is performed at about 40 ° C. to about 100 ° C., and the drying time may be appropriately changed depending on the ambient conditions, but is usually about 5 seconds to 3 minutes, particularly preferably about 40 ° C. to 80 ° C.
Seconds to 2 minutes.
【0058】次に本発明に用いられるハロゲン化銀写真
感光材料について説明する。本発明に用いられるハロゲ
ン化銀写真感光材料に含有される銀量は、支持体の両側
の合計として4.0g/m2 以下がよい。感光材料中の
銀量が4.0g/m 2 より多いと本発明の目的の一つで
ある環境負荷への低減が達成されなくなる。支持体の両
側に含有される銀量の合計はこのましくは3.6g/m
2 以下1.5g/m2 以上であり、特に3.2g/m2
以下2g/m2 以上であることがより好ましい。Next, a silver halide photograph used in the present invention
The photosensitive material will be described. Halogen used in the present invention
The amount of silver contained in the silver halide photographic light-sensitive material depends on both sides of the support.
Of 4.0g / m2The following is good. In the photosensitive material
Silver amount is 4.0g / m 2More is one of the purposes of the present invention
Reduction to a certain environmental load will not be achieved. Both sides of the support
The total amount of silver contained on the side is preferably 3.6 g / m
21.5g / m or less2Above, especially 3.2 g / m2
2 g / m or less2The above is more preferable.
【0059】本発明に用いられるの写真感光材料には必
要に応じてハロゲン化銀写真感光層以外に親水性コロイ
ド層を含有することでき、公知の方法に準じて表面保護
層を設けることが好ましい。乳剤層を含む親水性コロイ
ド層を有する側のゼラチン量は2.0g/m2 以上3.
2g/m2 未満の範囲にあることが好ましく、特に2.
2g/m2 以上3.0g/m2 未満の範囲にあることが
望ましい。本発明に用いられる写真感光材料のメルティ
ング・タイムは20分以上100分以下に設定されてい
ることが好ましい。ここで、メルティング・タイムの測
定方法は特開昭62−221341号に記載の方法に従
う。The photographic light-sensitive material used in the present invention may optionally contain a hydrophilic colloid layer in addition to the silver halide photographic light-sensitive layer, and it is preferable to provide a surface protective layer according to a known method. . 2. The amount of gelatin on the side having the hydrophilic colloid layer including the emulsion layer is 2.0 g / m 2 or more.
It is preferably in the range of less than 2 g / m 2 , particularly 2.
It is desirable to be in the range of 2 g / m 2 or more and less than 3.0 g / m 2 . The melting time of the photographic light-sensitive material used in the present invention is preferably set to 20 minutes or more and 100 minutes or less. Here, the measuring method of the melting time is according to the method described in JP-A-62-221341.
【0060】また、本発明に用いられる写真感光材料の
親水性コロイド層は、公知の硬膜剤により水中での膨潤
率が100%以上300%未満、特に150%以上25
0%以下に設定されていることが好ましい。ここで、膨
潤率とは特開昭58−111933号に記載されている
のと同一の定義によるものである。The hydrophilic colloid layer of the photographic light-sensitive material used in the present invention has a swelling ratio in water of 100% or more and less than 300%, particularly 150% or more and 25% by a known hardening agent.
It is preferably set to 0% or less. Here, the swelling rate has the same definition as described in JP-A-58-111933.
【0061】次に、本発明で用いられるハロゲン化銀写
真感光材料の乳剤粒子について説明する。本発明で用い
られるハロゲン化銀写真感光材料の少なくとも分散媒と
ハロゲン化銀粒子を含むハロゲン化銀乳剤は、好ましく
はCl- 含有率20〜100モル%、好ましくは30〜
100モル%、より好ましくは40〜100モル%、更
に好ましくは50〜100モル%のハロゲン化銀乳剤で
あり、該ハロゲン化銀粒子の全投影面積の50%以上、
好ましくは60%〜100%、より好ましくは70〜1
00%が主平面(100)又は(111)面である平板
状粒子である。ここに、平板状粒子とはアスペクト比
(直径/厚さ)が1より大きい粒子である。主平面は平
板状粒子の最大外表面を指す。該平板状粒子の厚さは
0.35μm以下であり0.05〜0.3μmがより好
ましく、0.05〜0.25μmが更に好ましい。平均
アスペクト比は2以上、好ましくは2〜25、より好ま
しくは5〜20である。ここで直径とは、該平板状粒子
の投影面積と等しい面積を有する円の直径を差し、厚さ
は2つの主平面間の距離を指す。平均アスペクト比とは
全平板状粒子のアスペクト比の平均である。Next, the emulsion grains of the silver halide photographic light-sensitive material used in the present invention will be described. The silver halide emulsion containing at least the dispersion medium and the silver halide grains of the silver halide photographic light-sensitive material used in the present invention preferably has a Cl - content of 20 to 100 mol%, preferably 30 to 100 mol%.
100 mol%, more preferably 40 to 100 mol%, further preferably 50 to 100 mol% of a silver halide emulsion, and 50% or more of the total projected area of the silver halide grains,
Preferably 60% to 100%, more preferably 70 to 1
Tabular grains having a major plane of (100) or (111) planes of 00%. Here, the tabular grains are grains having an aspect ratio (diameter / thickness) larger than 1. The principal plane refers to the maximum outer surface of tabular grains. The thickness of the tabular grains is 0.35 μm or less, more preferably 0.05 to 0.3 μm, still more preferably 0.05 to 0.25 μm. The average aspect ratio is 2 or more, preferably 2 to 25, more preferably 5 to 20. Here, the diameter means the diameter of a circle having an area equal to the projected area of the tabular grains, and the thickness means the distance between two principal planes. The average aspect ratio is the average aspect ratio of all tabular grains.
【0062】本発明の乳剤のうち(111)面を主平面
とする乳剤の核形成については、特公昭64−8326
号、同64−8325号、同64−8324号、特開平
1−250943号、特公平3−14328号、特公平
4−81782号、特公平5−40298号、同5−3
9459号、同5−12696号や特開昭63−213
836号、同63−218938号、同63−2811
49号、特開昭62−218959号等に詳しく述べら
れており、又、(100)面を主平面に有する平板状粒
子の先行技術としては、特開平5−204073号、特
開昭51−88017号、特開昭63−24238号、
特願平5−264059号等に述べられている。Among the emulsions of the present invention, the nucleation of the emulsion having the (111) plane as the principal plane is described in JP-B-64-8326.
No. 64-8325, No. 64-8324, JP-A No. 1-250943, Japanese Patent Publication No. 3-14328, Japanese Patent Publication No. 4-81782, Japanese Patent Publication No. 5-40298, 5-3.
No. 9459, No. 5-12696 and JP-A-63-213.
No. 836, No. 63-218938, No. 63-2811
49, JP-A-62-218959 and the like, and as the prior art of tabular grains having a (100) plane as the main plane, JP-A-5-204073 and 51- 88017, JP-A-63-24238,
It is described in Japanese Patent Application No. 5-264059.
【0063】本発明においては、これらの先行技術に記
載されている核形成方法を任意に用いることができる。
本発明のハロゲン化銀微粒子存在下の物理熟成(微粒子
が溶解し、基板粒子が成長する)により結晶成長する方
法について以下に記述する。微粒子乳剤添加法では0.
15μm径以下、好ましくは0.1μm径以下、より好
ましくは0.06〜0.006μm径のAgX微粒子乳
剤を添加し、オストワルド熟成により該平板状粒子を成
長させる。該微粒子乳剤は連続的に添加することもでき
るし、継続的に添加することもできる。該微粒子乳剤は
反応容器の近傍に設けた混合器でAgNO3 溶液とX-
塩溶液を供給して連続的に調製し、ただちに反応容器に
連続的に添加することもできるし、予め別の容器のバッ
チ式に調製した後に連続的もしくは継続的に添加するこ
ともできる。該微粒子乳剤は液状で添加することもでき
るし、乾燥した粉末として添加することもできる。該乾
燥粉末を添加直前に水と混合し、液状化して添加するこ
ともできる。添加した微粒子は20分以内に消失する態
様で添加することが好ましく、10秒〜10分がより好
ましい。消失時間が長くなると、微粒子間で熟成が生
じ、粒子サイズが大きくなる為に好ましくない。従って
一度に全量を添加しない方が好ましい。該微粒子は多量
双晶粒子を実質的に含まないことが好ましい。ここで多
重双晶粒子とは、1粒子あたり、双晶面を2枚以上有す
る粒子を指す。実質的に含まないとは、多重双晶粒子数
比率が5%以下、好ましくは1%以下、より好ましくは
0.1%以下を指す。更には1重双晶粒子をも実質的に
含まないことが好ましい。更にはらせん転位を実質的に
含まないことが好ましい。ここで実質的に含まないとは
前記規定に従う。In the present invention, any of the nucleation methods described in these prior arts can be used.
The method of crystal growth of the present invention by physical ripening in the presence of fine silver halide grains (fine grains are dissolved and substrate grains grow) is described below. In the fine grain emulsion addition method, it is 0.
An AgX fine grain emulsion having a diameter of 15 μm or less, preferably 0.1 μm or less, more preferably 0.06 to 0.006 μm is added, and the tabular grains are grown by Ostwald ripening. The fine grain emulsion can be added continuously or continuously. Fine grain emulsion is AgNO in mixer provided in the vicinity of the reaction vessel 3 solution and X -
The salt solution may be supplied and continuously prepared, and then immediately added continuously to the reaction vessel, or may be previously prepared in a batch manner in another vessel and then continuously or continuously added. The fine grain emulsion can be added in a liquid form or as a dry powder. It is also possible to mix the dry powder with water immediately before addition to liquefy it and add it. The added fine particles are preferably added in such a manner that they disappear within 20 minutes, more preferably 10 seconds to 10 minutes. If the disappearance time becomes long, ripening occurs between the fine particles and the particle size becomes large, which is not preferable. Therefore, it is preferable not to add the entire amount at once. It is preferable that the fine particles are substantially free of twinned grains. Here, the multi-twin grain means a grain having two or more twin planes per grain. The term "substantially free" means that the number ratio of multiple twinned grains is 5% or less, preferably 1% or less, more preferably 0.1% or less. Further, it is preferable that substantially no single twin crystal grains are contained. Furthermore, it is preferable that the screw dislocation is not substantially contained. Here, the term "substantially free" is in accordance with the above-mentioned rules.
【0064】該微粒子のハロゲン組成はAgCl、Ag
Br、AgBrl(I- 含率は10モル%以下が好まし
く、5モル%以下がより好ましい)およびそれらの2種
以上の混晶である。この他の詳細は特願平4−2141
09号の記載を参考にすることができる。微粒子の添加
総量は、全ハロゲン化銀量の20%以上が必要であり、
好ましくは、40%以上、さらに好ましくは、50%以
上98%以下である。該微粒子のCl含率は、10%以
上が好ましく、より好ましくは50%以上100%以下
が好ましい。The halogen composition of the fine particles is AgCl, Ag
Br, AgBrl (I - content is preferably 10 mol% or less, more preferably 5 mol% or less) and a mixed crystal of two or more thereof. For other details, see Japanese Patent Application No. 4-2141.
The description of No. 09 can be referred to. The total amount of fine grains added should be 20% or more of the total amount of silver halide.
It is preferably 40% or more, and more preferably 50% or more and 98% or less. The Cl content of the fine particles is preferably 10% or more, more preferably 50% or more and 100% or less.
【0065】核形成時、熟成時および成長時の分散媒と
しては従来公知のAgX乳剤用分散媒を用いることがで
きるが、特にメチオニン含率が好ましくは0〜50μモ
ル/g、より好ましくは0〜30μモル/gのゼラチン
を好ましく用いることができる。該ゼラチンが熟成、成
長時に用いられた場合、直径サイズ分布が揃ったより薄
い平板状粒子が形成され、好ましい。また、特公昭52
−16365号、日本写真学会誌、29巻(1)、1
7、22(1966年)、同30巻(1)、10、19
(1967年)、同30巻(2)、17(1967
年)、同33巻(3)、24(1967年)記載の合成
高分子を分散媒として好ましく用いることができる。微
粒子添加による成長時のpHは、2.0以上が必要であ
るが6以上、10以下が好ましい。さらに好ましくはp
H6以上9以下である。又、pClは1.0以上が必要
であるが、1.6以上が好ましい。さらに好ましくは
2.0以上3.0以下が好ましい。これらの成長条件
は、特に(100)面を主平面とする平板状粒子におい
て特に好ましいものである。ここでpClとは、溶液中
のClイオンの活量〔Cl- 〕に対し pCl=−log〔Cl- 〕 で定義される。T.H.James 著 THE THEORY OF THE RHOTO
GRAPHIC PROCESS 第4版 第1章に詳しく述べられて
いる。As a dispersion medium for nucleation, ripening and growth, a conventionally known dispersion medium for an AgX emulsion can be used, but the methionine content is preferably 0 to 50 μmol / g, more preferably 0. -30 μmol / g gelatin can be preferably used. When the gelatin is used during ripening and growth, thinner tabular grains having a uniform diameter size distribution are formed, which is preferable. In addition, Japanese Patent Publication Sho 52
-16365, Journal of the Photographic Society of Japan, Volume 29 (1), 1
7, 22 (1966), Volume 30 (1), 10, 19
(1967), Volume 30 (2), 17 (1967)
1), 33 (3), 24 (1967). The pH during growth due to addition of fine particles needs to be 2.0 or higher, but is preferably 6 or higher and 10 or lower. More preferably p
It is H6 or more and 9 or less. Further, pCl needs to be 1.0 or more, but 1.6 or more is preferable. It is more preferably 2.0 or more and 3.0 or less. These growth conditions are particularly preferable for tabular grains having the (100) plane as the main plane. Here pCl and the activity of Cl ions in the solution - to pCl = -log [Cl] - defined by [Cl]. THJames THE THEORY OF THE RHOTO
It is described in detail in Chapter 1 of the GRAPHIC PROCESS, 4th Edition.
【0066】pHが、2.0以下になってしまうと、例
えば(100)面を主平面にもつ平板状粒子の場合、横
方向の成長が抑制され、アスペクト比が下がり、乳剤の
カバーリングパワーは、低くなりがちで、かつ低感化し
てしまう。pH2.0以上であると、横方向の成長速度
が高くなり、高アスペクト比でカバーリングパワーも高
い乳剤が得られるが、カブリが高く低感化しやすい。p
Clが、1.0以下になるとたて方向の成長が促進さ
れ、アスペクト比が低下し、乳剤のカバーリングパワー
が低く、かつ低感化してしまう。pClが1.6以上に
なると高アスペクト比化してカバーリングパワーが増加
するがカブリが高く低感化しやすい。このとき、ハロゲ
ン化銀微粒子により基板粒子を成長させるとpHが6以
上及び又はpClが1.6以上でもカブリが低く、高感
でしかもより高アスペクト比で高カバーリングパワーと
なる。When the pH is 2.0 or less, for example, in the case of tabular grains having the (100) plane as the principal plane, lateral growth is suppressed and the aspect ratio is lowered, so that the emulsion covering power is reduced. Tends to be low, and the sensitivity becomes low. When the pH is 2.0 or more, the growth rate in the lateral direction becomes high, an emulsion having a high aspect ratio and a high covering power can be obtained, but fog is high and desensitization is likely to occur. p
When Cl is 1.0 or less, growth in the vertical direction is promoted, the aspect ratio is lowered, the covering power of the emulsion is low, and the sensitivity is lowered. When pCl is 1.6 or more, the aspect ratio is increased and the covering power is increased, but fog is high and the sensitivity is easily lowered. At this time, when the substrate particles are grown with silver halide fine particles, the fog is low even if the pH is 6 or more and / or the pCl is 1.6 or more, and the feeling is high and the aspect ratio is high and the covering power is high.
【0067】本発明の乳剤の単分散性については、単分
散度について特開昭59−745481に記載の方法で
定義した変動係数をもとに考えると、30%以下が好ま
しく、5%以上25%以下が好ましい。特に硬調な感材
に用いる場合には、5%以上15%以下が好ましい。Regarding the monodispersity of the emulsion of the present invention, when considering the monodispersity based on the coefficient of variation defined by the method described in JP-A-59-745481, it is preferably 30% or less and 5% or more and 25% or more. % Or less is preferable. Particularly when used for a sensitive material having a high contrast, it is preferably 5% or more and 15% or less.
【0068】本発明に好ましい増感方法であるセレン、
テルル増感について述べる。これらは、単独で用いられ
ても併用で用いられても良い。特にこれらの好ましい使
用例や化合物例は、例えば特開平3−116132号、
同5−113635号、同5−165136号、同5−
165137号、同5−134345号等に詳しく述べ
られている通りである。特に好ましく用いられるセレン
増感剤としては、例えば特開平5−165137号の一
般式(I)又は(II)で表わされる化合物及びそこに記
載された化合物例I−1〜I−20、II−1〜II−19
を挙げる事ができる。テルル増感剤に関しては特開平5
−134345号の一般式(IV)及び(V)で表わされ
る化合物及びそこに記載された化合物例IV−1〜IV−2
2及びV−1〜V−16を挙げることができる。Selenium, which is the preferred sensitization method in the present invention,
Tellurium sensitization is described. These may be used alone or in combination. Particularly preferred examples of use and compounds of these are described in, for example, JP-A-3-116132,
No. 5-113635, No. 5-165136, No. 5-
165137, 5-134345 and the like. As particularly preferred selenium sensitizers, for example, compounds represented by the general formula (I) or (II) of JP-A-5-165137 and compound examples I-1 to I-20, II- described therein 1-II-19
Can be mentioned. Regarding the tellurium sensitizer, it is disclosed in Japanese Patent Laid-Open No. H5-
-134345 Compounds represented by general formulas (IV) and (V) and compound examples IV-1 to IV-2 described therein
2 and V-1 to V-16 can be mentioned.
【0069】本発明の塩化銀含有平板状粒子の形成に
は、特開平4−139439、並びに特開平4−139
440、特開平4−139441並びに米国特許5,1
04,786に記載されている多重同軸ノズル等の装置
を用い、ハロゲン水溶液と硝酸銀水溶液の直前混合での
反応容器中への添加によって核形成ならびに成長を好ま
しく行なうことができる。本発明の感光材料に用いられ
る各種添加剤に関しては特に制限はなく、例えば特開平
2−68539号公報の以下の該当箇所に記載のものを
用いることができる。 項 目 該 当 箇 所 1.ハロゲン化銀乳剤と 特開平2−68539号公報第8頁右下欄下から6 その製法 行目から同第10頁右上欄12行目。 2.化学増感方法 同第10頁右上欄13行目から同左下欄16行目。 3.カブリ防止剤・安定 同第10頁左下欄17行目から同第11頁左上欄7 剤 行目及び同第3頁左下欄2行目から同第4頁左下欄 。 4.分光増感色素 同第4頁右下欄4行目から同第8頁右下欄。 5.界面活性剤・帯電防 同第11頁左上欄14行目から同第12頁左上欄9 止剤 行目。 6.マット剤・滑り剤・ 同第12頁左上欄10行目から同右上欄10行目。 可塑剤 同第14頁左下欄10行目から同右下欄1行目。 7.親水性コロイド 同第12頁右上欄11行目から同左下欄16行目。 8.硬膜剤 同第12頁左下欄17行目から同第13頁右上欄6 行目。 9.支持体 同第13頁右上欄7行目から20行目。 10. 染料・媒染剤 同第13頁左下欄1行目から同第14頁左下欄9行 目。For forming the tabular grains containing silver chloride of the present invention, JP-A-4-139439 and JP-A-4-139 are used.
440, Japanese Patent Laid-Open No. 4-139441 and US Pat.
Nucleation and growth can be preferably carried out by adding a halogen aqueous solution and a silver nitrate aqueous solution to the reaction vessel immediately before mixing using an apparatus such as a multiple coaxial nozzle described in No. 04,786. There are no particular restrictions on various additives used in the light-sensitive material of the present invention, and for example, those described in the following relevant parts of JP-A-2-68539 can be used. Item This section 1. Silver halide emulsion and JP-A-2-68539, page 8, lower right column, lower column, 6 from its manufacturing line, to page 10, upper right column, 12th column. 2. Chemical sensitization method, page 10, upper right column, line 13 to lower left column, line 16 3. Antifoggant / stabilization, page 10, lower left column, line 17 to page 11, upper left column, line 7 agent, and page 3, lower left column, line 2 to page 4, lower left column. 4. Spectral sensitizing dyes, page 4, lower right column, line 4 to page 8, lower right column. 5. Surfactant / antistatic, page 11, upper left column, line 14 to page 12, upper left column, line 9 antistatic agent. 6. Matting agent / slip agent ・ From page 12, upper left column, line 10 to upper right column, line 10 Plasticizer, page 14, lower left column, line 10 to lower right column, line 1 7. Hydrophilic colloid, page 12, upper right column, line 11 to lower left column, line 16 8. Hardener, page 12, lower left column, line 17 to page 13, upper right column, line 6 9. Support, page 13, upper right column, lines 7 to 20. 10. Dyes / mordanting agents, page 13, lower left column, line 1 to page 14, lower left column, line 9
【0070】本発明の感光材料を用いて画像を形成する
方法としては、好ましくは400nm以下に主ピークを
持つ蛍光体との組み合わせで画像形成する方法が良い。
さらに好ましくは380nm以下に主ピークを持つ蛍光
体と組み合わせて画像形成する方法が良い。400nm
以下に主発光ピークであるスクリーンは特開平6−11
804号、WO93/01521号に記載のスクリーン
などが使われるがこれに限られるものではない。As a method of forming an image using the light-sensitive material of the present invention, a method of forming an image in combination with a phosphor having a main peak at 400 nm or less is preferable.
More preferably, a method of forming an image by combining with a phosphor having a main peak at 380 nm or less is preferable. 400 nm
Below, the screen having the main emission peak is described in JP-A-6-11.
The screens described in No. 804 and WO93 / 01521 are used, but not limited to them.
【0071】本発明の感光材料の現像処理方法には、写
真感光材料として、特に限定はなく、一般の黒白感光材
料が主として用いられる。特にレーザー光源用写真材料
や印刷用感材並びに、医療用直接撮影X−レイ感材、医
療用間接撮影X−レイ感材、CRT画像記録用感材、マ
イクロフィルム、一般撮影感材などに用いることもでき
る。以下に実施例によって本発明を具体的に説明する
が、本発明はこれらに限定されるものではない。There are no particular restrictions on the photographic light-sensitive material used in the development processing method of the light-sensitive material of the present invention, and general black-and-white light-sensitive materials are mainly used. In particular, it is used for photographic materials for laser light sources, printing sensitive materials, medical direct photographing X-ray sensitive materials, medical indirect photographing X-ray sensitive materials, CRT image recording sensitive materials, microfilm, general photographing sensitive materials and the like. You can also The present invention will be specifically described below with reference to examples, but the present invention is not limited thereto.
【0072】[0072]
実施例1 (100)平板乳剤Aの調製 反応容器にゼラチン水溶液1582ml(ゼラチン−1
(メチオニン含率が約40μモル/gの脱イオン化アル
カリ処理骨ゼラチン)19.5g、HNO3 1N液7.
8mlを含み、pH4.3)、NaCl−1液(100ml
中にNaCl 10gを含む)を13ml入れ、温度を4
0℃に保ちながら、Ag−1液(100ml中にAgNO
3 20gを含む)とX−1液(100ml中にNaCl
7.05gを含む)を62.4ml/分で15.6mlずつ
同時混合添加した。3分間攪拌した後、Ag−2液(1
00ml中にAgNO3 2gを含む)とX−2液(100
ml中にKBr 1.4gを含む)を80.6ml/分で2
8.2mlずつ同時混合した。3分間攪拌した後、Ag−
1液とX−1液を62.4ml/分で46.8mlずつ同時
混合添加した。2分間攪拌した後、ゼラチン水溶液20
3ml(ゼラチン−113g、NaCl 1.3g、pH
6にするためにNaOH1N液を含む)を加え、pCl
を1.8とした後、温度を75℃に昇温し、pClを
1.8とした後42分間熟成した。AgCl微粒子乳剤
(平均粒子直径0.1μm)を2.68×10-2モル/
分のAgClの添加速度で20分添加した。添加後10
分間熟成した後、沈降剤を加え、温度を35℃に下げ、
沈降水洗した。ゼラチン水溶液を加え、60℃でpH
6.0に調節した。該粒子のレプリカの透過型電子顕微
鏡写真像(以下TEMと記す)を観察した。得られた粒
子は、銀を基準としてAgBrを0.44モル%含む高
塩化銀(100)平板粒子であった。該粒子の形状特性
値は下記のようであった。 (アスペクト比1より大の平板状粒子の全投影面積/全
AgX粒子の投影面積和)×100=a1 =90% (平板状粒子の平均アスペクト比(平均直径/平均厚
さ))=a2 =9.3 (平板状粒子の平均直径)=a3 =1.67μm (平均厚さ)=a4 =0.18μmExample 1 Preparation of (100) tabular emulsion A 1582 ml of gelatin aqueous solution (gelatin-1) was placed in a reaction vessel.
(Deionized alkali-treated bone gelatin having a methionine content of about 40 μmol / g) 19.5 g, HNO 3 1N liquid 7.
Containing 8 ml, pH 4.3, NaCl-1 solution (100 ml)
13 ml of NaCl (containing 10 g) was added and the temperature was adjusted to 4
While keeping the temperature at 0 ° C, Ag-1 solution (100 mL of AgNO
3 including 20 g) and X-1 solution (NaCl in 100ml
(Including 7.05 g) was simultaneously mixed and added at 62.4 ml / min in 15.6 ml portions. After stirring for 3 minutes, Ag-2 solution (1
AgNO 3 containing 2g) and X-2 solution in 100 ml (100
1.4g of KBr in ml) 80.6ml / min 2
Simultaneous mixing of 8.2 ml each. After stirring for 3 minutes, Ag-
Solution 1 and solution X-1 were simultaneously mixed and added at a rate of 62.4 ml / minute and 46.8 ml each. After stirring for 2 minutes, gelatin aqueous solution 20
3 ml (gelatin-113 g, NaCl 1.3 g, pH
(Including NaOH 1N solution to obtain 6), pCl
Was set to 1.8, the temperature was raised to 75 ° C., pCl was set to 1.8, and the mixture was aged for 42 minutes. AgCl fine grain emulsion (average grain diameter 0.1 μm) was 2.68 × 10 −2 mol /
The addition rate was 1 minute AgCl for 20 minutes. 10 after addition
After aging for a minute, a precipitating agent was added and the temperature was lowered to 35 ° C.
The precipitate was washed with water. Add gelatin aqueous solution, pH at 60 ℃
Adjusted to 6.0. A transmission electron micrograph image (hereinafter referred to as TEM) of the particle replica was observed. The obtained grains were high silver chloride (100) tabular grains containing 0.44 mol% of AgBr based on silver. The shape characteristic values of the particles were as follows. (Total projected area of tabular grains having an aspect ratio larger than 1 / sum of projected areas of all AgX grains) × 100 = a 1 = 90% (average aspect ratio (average diameter / average thickness) of tabular grains) = a 2 = 9.3 (average diameter of the tabular grains) = a 3 = 1.67 .mu.m (average thickness) = a 4 = 0.18 .mu.m
【0073】(111)平板乳剤Bの調製 塩化銀平板粒子を以下のように調製した。 (111) Preparation of Tabular Emulsion B Silver chloride tabular grains were prepared as follows.
【0074】[0074]
【化15】 [Chemical 15]
【0075】 [0075]
【0076】35℃に保った溶液(1)に、攪拌しなが
ら溶液(2)と溶液(3)を1分間かけて同時に加え、
溶液の温度を15分間かけて50℃に上昇させた。この
時点で全銀量の約5.7%に相当する粒子が形成され
た。次に、溶液(4)と溶液(5)を24分間かけて同
時に加え、さらに溶液(6)液と溶液(7)を40分間
かけて同時に添加し、塩化銀平板乳剤が得られた。乳剤
を沈降法により水洗・脱塩した後ゼラチン30gとH2
Oを加え、さらにフェノキシエタノール2.0g及び増
粘剤としてポリスチレンスルホン酸ナトリウム0.8g
を添加し、苛性ソーダでpH6.0になるように再分散
した。こうして得られた乳剤は、a1 =90%、a3 =
1.55μm、a4 =0.18μm、a2 =8.6、円
相当投影面積径の変動係数19%の(111)面を主平
面とした塩化銀平板乳剤である。Solution (2) and solution (3) were simultaneously added to solution (1) kept at 35 ° C. with stirring over 1 minute,
The temperature of the solution was raised to 50 ° C over 15 minutes. At this point, grains corresponding to about 5.7% of total silver were formed. Next, the solution (4) and the solution (5) were simultaneously added over 24 minutes, and the solution (6) and the solution (7) were simultaneously added over 40 minutes to obtain a silver chloride tabular emulsion. The emulsion was washed with water and desalted by the precipitation method, and then 30 g of gelatin and H 2
O was added, and further 2.0 g of phenoxyethanol and 0.8 g of sodium polystyrene sulfonate as a thickener.
Was added and redispersed with caustic soda to pH 6.0. The emulsion thus obtained had a 1 = 90% and a 3 =
It is a silver chloride tabular emulsion having a (111) plane as the main plane with 1.55 μm, a 4 = 0.18 μm, a 2 = 8.6, and a coefficient of variation of projected area diameter corresponding to circle of 19%.
【0077】平板状乳剤Cの調製 水1リットル中に臭化カリウム4.5g、塩化カリウム
1.5g、平均分子量1万5千の低分子量ゼラチン7.
0g、を添加し55℃に保った容器中へ攪拌しながら硝
酸銀水溶液37cc(硝酸銀4.00g)と臭化カリウム
5.9gを含む水溶液38ccをダブルジェット法により
37秒間で添加した。つぎにゼラチン18.6gを添加
した後70℃に昇温して硝酸銀水溶液89cc(硝酸銀
9.80g)を22分間かけて添加した。ここで25%
のアンモニア水溶液7ccを添加、そのままの温度で10
分間物理熟成したのち100%酢酸溶液を6.5cc添加
した。引き続いて硝酸銀153gの水溶液と臭化カリウ
ムの水溶液をpAg8.5に保ちながらコントロールダ
ブルジェット法で35分かけて添加した。次に2Nのチ
オシアン酸カリウム溶液15ccを添加した。5分間その
ままの温度で物理熟成したのち35℃に温度を下げた。
a1 =95%、平均投影面積直径a3 =1.50μm、
厚みa4 =0.185μm、平均アスペクト比a2 =
8.1、直径の変動係数18.5%の塩化銀含率24%
の単分散塩臭化銀平板状粒子を得た。この後、沈降法に
より可溶性塩類を除去した。再び40℃に昇温してゼラ
チン30gとフェノキシエタノール2.35gおよび増
粘剤としてポリスチレンスルホン酸ナトリウム0.8g
を添加し、苛性ソーダと硝酸銀溶液でpH5.90、p
Ag8.00に調整した。Preparation of Tabular Emulsion C 4.5 g of potassium bromide, 1.5 g of potassium chloride, and low molecular weight gelatin having an average molecular weight of 15,000 in 1 liter of water 7.
0 g of the solution was added to a container kept at 55 ° C. while stirring, and 37 cc of an aqueous solution of silver nitrate (4.00 g of silver nitrate) and 38 cc of an aqueous solution containing 5.9 g of potassium bromide were added in 37 seconds by the double jet method. Next, after adding 18.6 g of gelatin, the temperature was raised to 70 ° C. and 89 cc of silver nitrate aqueous solution (9.80 g of silver nitrate) was added over 22 minutes. 25% here
Add 7 cc of ammonia aqueous solution at 10 at the same temperature
After physically ripening for minutes, 6.5 cc of 100% acetic acid solution was added. Subsequently, an aqueous solution of 153 g of silver nitrate and an aqueous solution of potassium bromide were added over 35 minutes by the control double jet method while maintaining the pAg at 8.5. Next, 15 cc of 2N potassium thiocyanate solution was added. After physically aging for 5 minutes at the same temperature, the temperature was lowered to 35 ° C.
a 1 = 95%, average projected area diameter a 3 = 1.50 μm,
Thickness a 4 = 0.185 μm, average aspect ratio a 2 =
8.1, variation coefficient of diameter 18.5%, silver chloride content 24%
To obtain monodispersed silver chlorobromide tabular grains. After this, the soluble salts were removed by the sedimentation method. The temperature was raised to 40 ° C. again, and 30 g of gelatin, 2.35 g of phenoxyethanol and 0.8 g of sodium polystyrene sulfonate as a thickener.
Was added, and the pH was adjusted to 5.90 with a caustic soda solution and a silver nitrate solution.
It was adjusted to Ag 8.00.
【0078】化学増感 以上の如く調製した粒子A〜Cを攪拌しながら60℃に
保った状態で化学増感を施した。まず、チオスルホン酸
化合物−Iをハロゲン化銀1モルあたり10-4モル添加
し、つぎに直径0.10μmのAgBr微粒子を全銀量
に対して1.0モル%添加し、さらに二酸化チオ尿素を
1×10-6モル/モルAg添加し、22分間そのまま保
持して還元増感を施した。つぎに4−ヒドロキシ−6−
メチル−1,3,3a,7−テトラアザインデンを3×
10-4モル/モルAgと増感色素−1,2をそれぞれ添
加した。さらに塩化カルシウムを添加した。引き続きチ
オ硫酸ナトリウム(6×10-6モル/モルAg)及びセ
レン化合物−I(4×10 -6モル/モルAg)を添加し
た。さらに塩化金酸1×10-5モル/モルAgおよびチ
オシアン酸カリウム3.0×10-3モル/モルAgを添
加し、40分後に35℃に冷却した。こうして乳剤の調
製(化学熟成)を終了した。Chemical Sensitization The particles A to C prepared as described above were heated to 60 ° C. with stirring.
Chemical sensitization was carried out while maintaining. First, thiosulfonic acid
Compound-I was added in an amount of 10 per mol of silver halide.-FourMolar addition
Then, add AgBr fine particles with a diameter of 0.10 μm to the total silver amount.
1.0 mol% with respect to
1 × 10-6Add mol / mol Ag and hold for 22 minutes
I had it and gave reduction sensitization. Next, 4-hydroxy-6-
Methyl-1,3,3a, 7-tetraazaindene 3 ×
10-FourMol / mol Ag and sensitizing dyes-1, 2 respectively
Added Further calcium chloride was added. Continue to
Sodium sulphate (6 x 10-6Mol / mol Ag) and
Ren compound-I (4 x 10 -6Mol / mol Ag)
Was. Chloroauric acid 1 × 10-FiveMol / mol Ag and chi
Potassium cyanate 3.0 x 10-3Mol / mol Ag
After 40 minutes, the mixture was cooled to 35 ° C. Thus the emulsion tone
The production (chemical aging) was completed.
【0079】[0079]
【化16】 Embedded image
【0080】(乳剤塗布層の調製)化学増感を施した乳
剤に対してハロゲン化銀1モル当たり下記の薬品を添加
して乳剤塗布液とした。 ・ゼラチン(乳剤中のゼラチンも含めて) 111 g ・デキストラン(平均分子量3.9万) 21.5 g ・ポリアクリル酸ナトリウム(平均分子量40万) 5.1 g ・ポリスチレンスルホン酸ナトリウム(平均分子量60万) 1.2 g ・硬膜剤 1,2−ビス(ビニルスルホニルアセトアミド)エタン 膨潤率が230%の値になるように添加量を調整 ・化合物−I 42.1 mg ・化合物−II 10.3 g ・化合物−III 0.11g ・化合物−IV 8.5 mg ・化合物−V 0.43g ・化合物−VI 0.004g ・化合物−VII 0.1 g ・化合物−VIII 0.1 g NaOHでpH6.1に調整(Preparation of emulsion coating layer) An emulsion coating solution was prepared by adding the following chemicals to 1 mole of silver halide to the chemically sensitized emulsion.・ Gelatin (including gelatin in emulsion) 111 g ・ Dextran (average molecular weight 39,000) 21.5 g ・ Sodium polyacrylate (average molecular weight 400,000) 5.1 g ・ Sodium polystyrene sulfonate (average molecular weight 600,000) 1.2 g-Hardener 1,2-bis (vinylsulfonylacetamide) ethane Addition amount is adjusted so that the swelling rate is 230% -Compound-I 42.1 mg-Compound-II 10.3 g-Compound-III 0.11 g- Compound-IV 8.5 mg-Compound-V 0.43 g-Compound-VI 0.004 g-Compound-VII 0.1 g-Compound-VIII 0.1 g pH adjusted to 6.1 with NaOH
【0081】[0081]
【化17】 [Chemical 17]
【0082】[0082]
【化18】 Embedded image
【0083】上記塗布液に対し、紫外線吸収染料−I〜
III が各々片面当たり10mg/m2となるように染料乳化
物Aを添加した。With respect to the above coating solution, ultraviolet absorbing dye-I-
Dye emulsion A was added so that III was 10 mg / m 2 on each side.
【0084】[0084]
【化19】 [Chemical 19]
【0085】(染料乳化物Aの調製)上記染料−I〜II
I を各々20gおよび下記高沸点有機溶媒−Iを62.
8g、−IIを62.8g及び酢酸エチル333gを60
℃で溶解した。つぎにドデシルスルホン酸ナトリウムの
5%水溶液65ccとゼラチン94g、水581ccを添加
し、ディゾルバーにて60℃、30分間乳化分散した。
つぎに下記化合物−IXを2gおよび水6リットルを加
え、40℃に降温した。つぎに旭化成製限外濾過ラボモ
ジュールACP1050を用いて、全量が2kgとなるま
で濃縮し、前記化合物−IXを1g加えて染料乳化物Aと
した。(Preparation of Dye Emulsion A) The above Dyes-I to II
20 g of each I and 62.
8 g, 62.8 g of -II and 60 g of 333 g of ethyl acetate.
Melted at ° C. Next, 65 cc of a 5% aqueous solution of sodium dodecyl sulfonate, 94 g of gelatin and 581 cc of water were added, and the mixture was emulsified and dispersed by a dissolver at 60 ° C. for 30 minutes.
Next, 2 g of the following compound-IX and 6 liters of water were added, and the temperature was lowered to 40 ° C. Next, using Asahi Kasei's ultrafiltration laboratory module ACP1050, the total amount was concentrated to 2 kg, and 1 g of the compound-IX was added to obtain a dye emulsion A.
【0086】[0086]
【化20】 Embedded image
【0087】(表面保護層塗布液の調製)表面保護層塗
布液を、各成分が下記の塗布量となるように調製した。 ・ゼラチン 0.780g/m2 ・ポリアクリル酸ナトリウム(平均分子量40万) 0.035 ・ポリスチレンスルホン酸ナトリウム(平均分子量60万) 0.0012 ・ポリメチルメタクリレート(平均粒径3.7μm) 0.036 ・ポリメチルメタクリレート/スチレン/メタクリル酸 共重合体(共重合比70/20/10モル%)(平均粒径3.7 μm) 0.036 ・塗布助剤−I 0.020 ・塗布助剤−II 0.037 ・塗布助剤−III 0.0080 ・塗布助剤−IV 0.0032 ・塗布助剤−V 0.0025 ・塗布助剤−VII 0.0022 ・プロキセル 0.0010 (NaOHでpH6.8に調整)(Preparation of Coating Solution for Surface Protective Layer) A coating solution for surface protective layer was prepared so that each component had the following coating amount.・ Gelatin 0.780 g / m 2・ Sodium polyacrylate (average molecular weight 400,000) 0.035 ・ Sodium polystyrene sulfonate (average molecular weight 600,000) 0.0012 ・ Polymethyl methacrylate (average particle size 3.7 μm) 0.036 ・ Polymethyl methacrylate / styrene / Methacrylic acid copolymer (copolymerization ratio 70/20/10 mol%) (average particle size 3.7 μm) 0.036 ・ Coating aid-I 0.020 ・ Coating aid-II 0.037 ・ Coating aid-III 0.0080 ・ Coating aid Agent-IV 0.0032 ・ Coating aid-V 0.0025 ・ Coating aid-VII 0.0022 ・ Proxel 0.0010 (pH adjusted to 6.8 with NaOH)
【0088】[0088]
【化21】 [Chemical 21]
【0089】(支持体の調製)二軸延伸された厚さ17
5μmのポリエチレンテレフタレートフィルム上にコロ
ナ放電を行い、下記の組成より成る第1下塗液を塗布量
が4.9cc/m2と成るようにワイヤーコンバーターによ
り塗布し、185℃にて1分間乾燥した。つぎに反対面
にも同様にして第1下塗層を設けた。使用したポリエチ
レンテレフタレートには染料−IVが0.06wt%、染
料−Vが0.06wt%含有されているものを用いた。(Preparation of Support) Biaxially Stretched Thickness 17
Corona discharge was performed on a polyethylene terephthalate film having a thickness of 5 μm, and a first undercoating liquid having the following composition was applied by a wire converter so that the applied amount was 4.9 cc / m 2, and dried at 185 ° C. for 1 minute. Next, a first undercoat layer was similarly provided on the opposite surface. The polyethylene terephthalate used was one containing 0.06 wt% of dye-IV and 0.06 wt% of dye-V.
【0090】[0090]
【化22】 [Chemical formula 22]
【0091】 ・ブタジエン−スチレン共重合体ラテックス溶液 (固形分40%ブタジエン/スチレン重量比=31/69) 158 cc ・2,4−ジクロロ−6−ヒドロキシ−s−トリアジンナトリウム 塩4%溶液 41 cc ・蒸留水 801 cc ※ラテックス溶液中には、乳化分散剤として下記化合物をラテックス固形分に 対し0.4wt%含有-Butadiene-styrene copolymer latex solution (solid content 40% butadiene / styrene weight ratio = 31/69) 158 cc-2,4-dichloro-6-hydroxy-s-triazine sodium salt 4% solution 41 cc・ Distilled water 801 cc * The latex solution contains the following compounds as an emulsifying dispersant in an amount of 0.4 wt% of the latex solids.
【0092】[0092]
【化23】 [Chemical formula 23]
【0093】(写真材料の調製)前述のごとく準備した
支持体上に先の乳剤層と表面保護層とを組み合わせ同時
押し出し法により両面に塗布した。片面当りの塗布銀量
は1.75g/m2とした。この様にして表1の試料を作
製した。(Preparation of Photographic Material) The above-prepared support was combined with the above emulsion layer and surface protective layer and coated on both sides by the simultaneous extrusion method. The coated silver amount per one side was 1.75 g / m 2 . In this way, the samples shown in Table 1 were prepared.
【0094】[0094]
【表1】 [Table 1]
【0095】表1の写真材料を富士写真フイルム(株)
製オルソスクリーンHR−4をカセッテを使用して両面
に密着させ、両面から0.05秒の露光を与え、X線セ
ンシトメトリーを行った。露光量の調製は、X線管球と
カセッテとの距離を変化させることにより行った。露光
後、富士写真フイルム(株)社製の自動現像機CEPR
OS−30をもちいて、補充量を改造して現像補充液お
よび定着補充液を感光材料1m2あたり103ml補充しな
がら、下記に示した温度および時間で毎日30枚処理
し、約1カ月ランニングを行い、ランニング前およびラ
ンニング終了後のセンシトメトリーを得た。 工 程 温 度 処理時間 現 像 35℃ 8.8秒 定 着 32℃ 7.7秒 水 洗 17℃ 3.8秒 スクイズ 4.4秒 乾 燥 58℃ 5.3秒 合 計 − 30 秒 (濃縮現像液の調製) <現像液> パーツ剤A 水酸化カリウム 330 g 亜硫酸カリウム 630 g 亜硫酸ナトリウム 255 g 炭酸カリウム 90 g ホウ酸 45 g ジエチレングリコール 180 g ジエチレントリアミン五酢酸 30 g 1−(N,N−ジエチルアミン)エチル−5−メルカプト テトラゾール 0.75g 表2記載の現像主薬 表2記載の量 4−ヒドロキシメチル−4−メチル−1−フェニル−3− ピラゾリドン 表2記載の量 水を加えて 4125 mlFuji Photo Film Co., Ltd. was used as the photographic material of Table 1.
The orthoscreen HR-4 manufactured by Kabushiki Kaisha was adhered to both sides using a cassette, and exposed for 0.05 seconds from both sides, and X-ray sensitometry was performed. The exposure amount was adjusted by changing the distance between the X-ray tube and the cassette. After exposure, Fuji Photo Film Co., Ltd. automatic processor CEPR
Using OS-30, the replenishing amount was modified to replenish the developing replenisher and the fixing replenisher with 103 ml per 1 m 2 of the light-sensitive material, and 30 sheets were processed every day at the temperature and time shown below to run for about one month. Then, sensitometry before and after running was obtained. Process Temperature Treatment time Current image 35 ° C 8.8 seconds Settling 32 ° C 7.7 seconds Water washing 17 ° C 3.8 seconds Squeeze 4.4 seconds Dry 58 ° C 5.3 seconds Total -30 seconds (concentration Preparation of developer) <Developer> Part agent A potassium hydroxide 330 g potassium sulfite 630 g sodium sulfite 255 g potassium carbonate 90 g boric acid 45 g diethylene glycol 180 g diethylenetriaminepentaacetic acid 30 g 1- (N, N-diethylamine) Ethyl-5-mercaptotetrazole 0.75 g Developing agent listed in Table 2 Amount listed in Table 2 4-Hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidone Amount listed in Table 2 Water added 4125 ml
【0096】 パーツ剤B ジエチレングリコール 525 g 表2記載の化合物 表2記載の量 氷酢酸 102.6g 2−ニトロインダゾール 3.75g 1−フェニル−3−ピラゾリドン 34.5 g 水を加えて 750 mlParts agent B Diethylene glycol 525 g Compound shown in Table 2 Amount shown in Table 2 Glacial acetic acid 102.6 g 2-Nitroindazole 3.75 g 1-Phenyl-3-pyrazolidone 34.5 g Water 750 ml
【0097】 パーツ剤C グルタールアルデヒド(50wt/wt%) 150 g 臭化カリウム 15 g メタ重亜硫酸カリウム 105 g 水を加えて 750 mlParts agent C Glutaraldehyde (50 wt / wt%) 150 g Potassium bromide 15 g Potassium metabisulfite 105 g Water 750 ml
【0098】[0098]
【表2】 [Table 2]
【0099】 <定着液> チオ硫酸アンモニウム(70wt/vol %) 3000 ml エチレンジアミン四酢酸・二ナトリウム・二水塩 0.45 g 亜硫酸ナトリウム 225 g グルコン酸ナトリウム 15 g 1−(N,N−ジエチルアミン)−エチル−5−メルカプ トテトラゾール 15 g 酒石酸 48 g 氷酢酸 675 g 水酸化ナトリウム 225 g 硫酸(36N) 58.5 g 硫酸アルミニウム 150 g 水を加えて 6000 ml pH 4.68<Fixer> Ammonium thiosulfate (70 wt / vol%) 3000 ml Ethylenediaminetetraacetic acid / disodium dihydrate 0.45 g Sodium sulfite 225 g Sodium gluconate 15 g 1- (N, N-diethylamine) -ethyl- 5-mercaptotetrazole 15 g Tartaric acid 48 g Glacial acetic acid 675 g Sodium hydroxide 225 g Sulfuric acid (36N) 58.5 g Aluminum sulfate 150 g Water 6000 ml pH 4.68
【0100】(処理液の調製)上記の濃縮現像液を下記
の容器に各パーツ剤毎に充填した。この容器はパーツ剤
A、B、Cの各部分容器が容器自身によって一つに連結
されているものである。また、上記濃縮定着液も同種の
容器に充填した。まず、現像槽内にスターターとして、
酢酸54gと臭化カリウム55.5gを含む水溶液30
0mlを添加した。上記処理剤入容器を逆さにして自現機
の側面に装着されている処理液ストックタンクの穿孔刃
にさしこんで、キャップの封止膜を破り、容器内の各処
理剤をストックタンクに充填した。これらの各処理剤を
下記の割合で自現機の現像槽、定着槽に、それぞれ自現
機に設置されているポンプを作動して満たした。また、
感材が4切サイズ換算で8枚処理される毎にも、この割
合で、処理剤原液と水とを混合して自現機の処理槽に補
充した。(Preparation of Processing Solution) The above concentrated developer was filled in the following containers for each parts agent. In this container, the partial containers of the parts agents A, B and C are connected together by the container itself. The concentrated fixing solution was also filled in the same kind of container. First, as a starter in the developing tank,
Aqueous solution 30 containing 54 g of acetic acid and 55.5 g of potassium bromide
0 ml was added. Insert the above treatment agent container upside down and insert it into the perforation blade of the treatment solution stock tank mounted on the side of the automatic processing machine to break the sealing film of the cap and transfer each treatment agent in the container to the stock tank. Filled. These processing agents were filled in the developing tank and fixing tank of the developing machine at the following ratios by operating the pumps installed in the developing machine. Also,
Every time 8 sheets of photosensitive material were processed in terms of 4-cut size, the processing agent stock solution and water were mixed at this ratio and replenished in the processing tank of the developing machine.
【0101】現像液 パーツ液A 25 ml パーツ液B 5 ml パーツ液C 5 ml 水 65 ml pH 10.50 定着液 濃縮液 40 ml 水 60 ml pH 4.62 水洗槽には水道水を満たした。Developer solution Part solution A 25 ml Part solution B 5 ml Part solution C 5 ml Water 65 ml pH 10.50 Fixer concentrate 40 ml Water 60 ml pH 4.62 The wash tank was filled with tap water.
【0102】また、水あか防止剤として、放線菌を平均
粒径100μm、平均孔径3μmのパーライトに担持さ
せたもの0.4gをポリエチレン製のビン(ビン開口部
を300メッシュのナイロン布で覆い、この布より水お
よび菌の流通が可能)に充填したものを3個用意し、そ
のうちの2個を水洗槽の底部に、1個を水洗水のストッ
クタンク(液量0.2リットル)の底部にそれぞれ沈め
た。As a water stain inhibitor, 0.4 g of actinomycetes supported on perlite having an average particle size of 100 μm and an average pore size of 3 μm was covered with a polyethylene bottle (the bottle opening was covered with a 300-mesh nylon cloth. Prepare three pieces filled with water and fungi from the cloth), two of them at the bottom of the washing tank, and one at the bottom of the stock tank for washing water (liquid volume 0.2 liters). I sunk each.
【0103】(写真性の評価)写真性の評価は、次のよ
うに行った。感度は現像液7の新液で感材を処理したと
きに濃度1.0を得るのに要した露光量の逆数を100
として相対的に示した。階調は濃度2.0と濃度0.2
5の差を濃度2.0を与える露光量の対数と濃度0.2
5を与える露光量の対数との差で割った値で示した。(Evaluation of Photographic Property) Photographic property was evaluated as follows. The sensitivity is 100, which is the reciprocal of the exposure amount required to obtain a density of 1.0 when a photosensitive material is treated with a new solution of developer 7.
As relative. Gradation is density 2.0 and density 0.2
The difference of 5 gives a density of 2.0 and the logarithm of the exposure dose and a density of 0.2
It is shown as a value divided by the difference from the logarithm of the exposure amount giving 5.
【0104】[0104]
【表3】 [Table 3]
【0105】表3に示すように現像主薬としてハイドロ
キノンモノスルフォネートもしくはその誘導体及び超加
成性を示す補助現像主薬を含有し、さらに一般式(I)
及び/又は(II)で表される化合物を含有する本発明の
現像液で処理することによって、ハイドロキノンを現像
主薬とする現像液の場合と同様にランニングの前後で安
定した写真性が得られ、自現機の処理タンク及びローラ
ーに銀汚れが付着しない処理方法が得られた。As shown in Table 3, hydroquinone monosulfonate or a derivative thereof as a developing agent and an auxiliary developing agent exhibiting superadditivity are contained, and further, the compound represented by the general formula (I) is used.
And / or (II) by treatment with a developer of the present invention containing a compound, stable photographic properties are obtained before and after running as in the case of a developer containing hydroquinone as a developing agent, A processing method was obtained in which silver stains did not adhere to the processing tank and rollers of the automatic processing machine.
【0106】実施例2 (ハロゲン化銀感光材料の調整)ハロゲン化銀感光材料
は実施例1で用いたものと全く同じものを使用した。Example 2 (Preparation of silver halide photosensitive material) The same silver halide photosensitive material as that used in Example 1 was used.
【0107】(濃縮現像液の調製)下記処方の本発明の
ハイドロキノンモノスルフォネートもしくはその誘導体
を現像主薬、超加成性を示す補助現像主薬、及び一般式
(I)及び/又は(II)で表される化合物を含有する濃
縮現像液を調整した。(Preparation of Concentrated Developer) The hydroquinone monosulfonate or its derivative of the present invention having the following formulation is used as a developing agent, an auxiliary developing agent exhibiting superadditivity, and general formulas (I) and / or (II). A concentrated developer containing a compound represented by
【0108】 ジエチレントリアミン五酢酸 8.0 g 亜硫酸ナトリウム 50.0 g 炭酸ナトリウム・1水塩 52.0 g 炭酸カリウム 55.0 g 本発明の現像主薬III−1 120.0 g 4−ヒドロキシメチル−4−メチル −1−フェニル−3−ピラゾリドン 13.2 g 化合物II−14 1.44g ジエチレングリコール 50.0 g 水酸化ナトリウムでpH12.0に調整する。 水を加えて1リットルとする。Diethylenetriamine pentaacetic acid 8.0 g Sodium sulfite 50.0 g Sodium carbonate monohydrate 52.0 g Potassium carbonate 55.0 g Developer III-1 120.0 g 4-hydroxymethyl-4 of the present invention -Methyl-1-phenyl-3-pyrazolidone 13.2 g Compound II-14 1.44 g Diethylene glycol 50.0 g Adjust to pH 12.0 with sodium hydroxide. Add water to make 1 liter.
【0109】(現像補充液の調整)上記濃縮現像液を2
倍希釈し、現像補充液として使用した。(Preparation of development replenisher)
It was diluted twice and used as a development replenisher.
【0110】(現像母液の調製)上記濃縮現像液2リッ
トルを水で希釈し4リットルとし、下記組成のスタータ
液を希釈した現像液1リットルあたり20ml添加、p
H11.8の現像液を現像母液とした。 スタータ液 臭化カリウム 3.7g 酢酸 3.6g 水を加えて20mlとする(Preparation of developing mother liquor) 2 liters of the above concentrated developer was diluted to 4 liters with water, and 20 ml was added to 1 liter of the diluted starter solution having the following composition, p
The developing solution of H11.8 was used as the developing mother solution. Starter solution Potassium bromide 3.7 g Acetic acid 3.6 g Water is added to make 20 ml.
【0111】(濃縮定着液の調製)以下の組成の定着液
を調製した。 水 5 l エチレンジアミンテトラ酢酸・2水塩 0.5g チオ硫酸ナトリウム・5水塩 2900 g 重亜硫酸ナトリウム 491 g 水酸化ナトリウム 47.3g 水を加えて10リットルとする(濃縮液)(pH=5.42)(Preparation of Concentrated Fixing Solution) A fixing solution having the following composition was prepared. Water 5 l Ethylenediaminetetraacetic acid dihydrate 0.5 g Sodium thiosulfate pentahydrate 2900 g Sodium bisulfite 491 g Sodium hydroxide 47.3 g Water is added to make 10 liters (concentrated liquid) (pH = 5. 42)
【0112】(定着補充液の調整)上記濃縮定着液を2
倍希釈し、定着補充液として使用した。(Preparation of Fixing Replenisher)
It was diluted twice and used as a fixing replenisher.
【0113】(定着母液の調製)上記濃縮定着液2リッ
トルを水で希釈し4リットルとした。pHは5.6であ
った。(Preparation of fixing mother liquor) 2 liters of the concentrated fixing solution was diluted with water to 4 liters. The pH was 5.6.
【0114】(写真材料の露光及び処理)実施例1で調
製した写真感光材料を富士写真フイルム(株)製オルソ
スクリーンHG−Mをカセッテを使用して両面に密着さ
せ、両面から0.05秒の露光を与え、X線センシトメ
トリーを行った。露光量の調整は、X線管球とカセッテ
との距離を変化させることにより調製した。露光後、駆
動系及び開口率を0.02に改良した富士写真フイルム
(株)社製の自動現像機FPM−800で、上記現像母
液及び定着母液を用いて、現像補充液及び定着補充液を
感光材料1m2 当たり130ml補充しながら、600
枚処理した。 工程 温度 処理時間 現像 35℃ 25秒 定着 35℃ 25秒 水洗 18℃ 22秒 乾燥 55℃ 40秒 合計(dry to dry) 120秒(Exposure and Processing of Photographic Material) The photographic light-sensitive material prepared in Example 1 was adhered to both sides of an orthoscreen HG-M manufactured by Fuji Photo Film Co., Ltd. using a cassette, and 0.05 seconds from both sides. Exposure was performed and X-ray sensitometry was performed. The exposure amount was adjusted by changing the distance between the X-ray tube and the cassette. After the exposure, an automatic developing machine FPM-800 manufactured by Fuji Photo Film Co., Ltd. in which the driving system and the aperture ratio were improved to 0.02 was used to develop a developing replenisher and a fixing replenisher by using the developing mother liquor and the fixing mother liquor. 600 ml while replenishing 130 ml per 1 m 2 of light-sensitive material
One sheet was processed. Process Temperature Processing time Development 35 ° C 25 seconds Fixing 35 ° C 25 seconds Water washing 18 ° C 22 seconds Drying 55 ° C 40 seconds Total (dry to dry) 120 seconds
【0115】(写真性の評価)写真性の評価は実施例1
と全く同様の方法で評価した。(Evaluation of Photographic Property) Photographic property was evaluated in Example 1.
Evaluation was made in exactly the same manner as.
【0116】実施例2においても、実施例1同様現像主
薬としてハイドロキノンモノスルフォネートもしくはそ
の誘導体及び超加成性を示す補助現像主薬を含有し、さ
らに一般式(I)及び/又は(II)で表される化合物を
含有する本発明の現像液で処理することによって、ハイ
ドロキノンを現像主薬とする現像液の場合と同様にラン
ニングの前後で安定した写真性が得られ、自現機の処理
タンク及びローラーに銀汚れが付着しない処理方法が得
られた。Also in Example 2, as in Example 1, hydroquinone monosulfonate or its derivative as a developing agent and an auxiliary developing agent exhibiting superadditivity are contained, and further the general formula (I) and / or (II) is used. By processing with the developing solution of the present invention containing a compound represented by the following, stable photographic properties can be obtained before and after running as in the case of a developing solution containing hydroquinone as a developing agent, and a processing tank of a developing machine is obtained. And a processing method was obtained in which silver stains did not adhere to the rollers.
【0117】実施例3 実施例1で作成した写真感光材料を下記の様な現像液で
処理を行なった。 〔自動現像機処理〕自動現像機は富士写真フイルム
(株)製の「富士XレイプロセサーCEPROS−M〕
を用いて全処理時間が90秒になるようにした。乾燥吹
出温度は55℃に設定した。 現像液処方 PartA 水酸化カリウム 18.0 g 亜硫酸カリウム 30.0 g 炭酸ナトリウム 30.0 g ジエチレングリコール 10.0 g ジエチレントリアミン五酢酸 2.0 g 1−(N,N−ジエチルアミノ)エチル−5−メルカプト テトラゾール 0.1 g 本発明の現像主薬III −1 45.0 g 4−ヒドロキシメチル−4−メチル−1−フェニル−3− ピラゾリドン 3.0 g 水を加えて 300 mlExample 3 The photographic light-sensitive material prepared in Example 1 was processed with the following developer. [Automatic processor processing] The automatic processor is "Fuji X Ray Processor CEPROS-M" manufactured by Fuji Photo Film Co., Ltd.
Was used so that the total processing time was 90 seconds. The dry blowing temperature was set to 55 ° C. Developer formulation PartA Potassium hydroxide 18.0 g Potassium sulfite 30.0 g Sodium carbonate 30.0 g Diethylene glycol 10.0 g Diethylenetriamine pentaacetic acid 2.0 g 1- (N, N-diethylamino) ethyl-5-mercaptotetrazole 0.1 g Developer III-1 of the present invention 45.0 g 4-hydroxymethyl-4-methyl-1-phenyl-3-pyrazolidone 3.0 g Water added 300 ml
【0118】 PartB トリエチレングリコール 45.0 g 本発明の化合物II−14 0.2 g 氷酢酸 5.0 g 5・ニトロインダゾール 0.3 g 1−フェニル−3−ピラゾリドン 5.5 g 水を加えて 60 mlPart B Triethylene glycol 45.0 g Compound II-14 of the present invention 0.2 g Glacial acetic acid 5.0 g 5-nitroindazole 0.3 g 1-Phenyl-3-pyrazolidone 5.5 g Water 60 ml
【0119】 PartC グルタールアルデヒド(50%) 10.0 g 臭化カリウム 4.0 g メタ重亜硫酸カリウム 10.0 g 水を加えて 50 ml PartA 300mlとPartB 60ml とPartC 50m
l に水を加えて1リットルとしてpH10.90に合わ
せる。PartA 4.50リットル、PartB 0.90リ
ットル、PartC 0.75リットルを富士フイルム
(株)社製CE−DF1ボトルに使用液15リットル用
として充填して使用した。 現像開始液 前記現像補充液に酢酸を添加してpH=10.20にし
たものを現像開始液とした。PartC Glutaraldehyde (50%) 10.0 g Potassium bromide 4.0 g Potassium metabisulfite 10.0 g Water was added to 50 ml PartA 300 ml, PartB 60 ml and PartC 50m.
Add water to 1 to make 1 liter and adjust to pH 10.90. Part A 4.50 liters, Part B 0.90 liters, and Part C 0.75 liters were used by filling a CE-DF1 bottle manufactured by FUJIFILM Corporation for 15 liters of the working solution. Development Starter Solution Acetic acid was added to the development replenisher solution to adjust the pH to 10.20, which was used as a development starter solution.
【0120】定着液としては富士写真フイルム(株)社
製CE−F1を使用した。 現像温度………35℃ 定着温度………35℃ 乾燥温度………55℃ 補充量(現像液、定着液ともに)12.5ml/10×2
1インチ(161ml/m2)各試料10×12インチサイ
ズフィルムを600枚ランニング処理を行なったところ
本発明の現像液は良好な性能が得られた。As the fixing solution, CE-F1 manufactured by Fuji Photo Film Co., Ltd. was used. Development temperature: 35 ° C Fixing temperature: 35 ° C Drying temperature: 55 ° C Replenishment amount (both developer and fixer) 12.5ml / 10 × 2
When the 1-inch (161 ml / m 2 ) sample 10 × 12-inch size film was subjected to running processing on 600 sheets, the developer of the present invention showed good performance.
【0121】実施例4 実施例1で用いた感材を特開平6−11804号に記載
の蛍光体スクリーンを用いX線露光での画像形成を行
い、実施例1の本発明の現像液3で処理したところ、良
好なX線画像が形成されることが確認された。なお、本
実施例1、2、3及び4において富士医療用X−レイフ
ィルム、スーパーHRA−30、スーパーHR−S3
0、スーパーHR−G30、スーパーHR−HA30、
スーパーHR−L30、UR−1、UR−2等で処理を
行っても本実施例1、2、3及び4と同様の効果を示し
たことを記しておく。Example 4 The light-sensitive material used in Example 1 was subjected to image formation by X-ray exposure using the phosphor screen described in JP-A-6-11804, and the developer 3 of the invention of Example 1 was used. Upon processing, it was confirmed that a good X-ray image was formed. In addition, in Examples 1, 2, 3 and 4, the Fuji medical X-ray film, Super HRA-30, and Super HR-S3 were used.
0, Super HR-G30, Super HR-HA30,
It should be noted that the same effects as those of Examples 1, 2, 3 and 4 were exhibited even when the treatment was carried out with Super HR-L30, UR-1, UR-2 and the like.
【0122】好ましい実施態様 1 ハロゲン化銀粒子の塩化銀が10〜100モル%、
臭化銀が10〜100モル%、沃化銀が0〜5モル%で
あるハロゲン化銀写真感光材料を用いることを特徴とす
る請求項1又は請求項2の処理方法。 2 請求項1の現像液を用いて全処理時間(Dry to Dr
y)が20秒〜100秒であることを特徴とする処理方
法。 3 請求項1の現像液を用いて自動現像処理装置の乾燥
部の前段に感光材料が接触するローラー部分の加熱手段
が70℃以上であることを特徴とする処理方法。 4 自動現像処理装置にケミカルミキサーを内蔵する
際、現像液と定着液のカートリッジが同時に使い終わる
機構を有する自動現像処理装置であることを特徴とする
処理方法。Preferred Embodiment 1 The silver halide grains contain 10 to 100 mol% of silver chloride,
3. The processing method according to claim 1 or 2, wherein a silver halide photographic light-sensitive material containing 10 to 100 mol% of silver bromide and 0 to 5 mol% of silver iodide is used. 2 The total processing time (Dry to Dr.
y) is 20 seconds to 100 seconds. 3. A processing method using the developing solution according to claim 1, wherein the heating means for the roller portion in contact with the photosensitive material before the drying portion of the automatic development processing device is at 70 ° C. or higher. (4) A processing method characterized by an automatic development processing apparatus having a mechanism in which a developer and a fixing solution cartridge are used up at the same time when a chemical mixer is built into the automatic development processing apparatus.
【0123】5 請求項1の現像液を用いる自動現像処
理装置の現像タンクの開口率が0.04cm-1以下である
ことを特徴とする処理方法。 6 現像濃縮液と定着濃縮液が1パーツから成り各濃縮
液と水とが各タンク内で使用液に希釈されて、補充液と
して供給される(直前混合希釈方式)ことを特徴とする
処理方法。 7 請求項1の現像濃縮液と定着濃縮液の容器が一体型
包剤であることを特徴とする処理方法。 8 請求項1の現像液を用いた現像槽と定着槽間および
定着槽と水洗槽間にリンス槽およびリンスローラー(ク
ロスオーバーローラー)を設置した自動現像機を用いる
ことを特徴とする処理方法。 9 各種水アカ防止剤(防菌剤)が水洗槽およびリンス
槽に供給される水のストック槽が設置された自動現像機
を用いることを特徴とする処理方法。 10 水洗槽の排水口に電磁弁が設置された自動現像機を
用いることを特徴とする処理方法。 11 現像液中の全陽イオンの70モル%以上がカリウム
イオンであることを特徴とする請求項1の現像剤。 12 現像液が粉体であることを特徴とする請求項1の現
像剤。 13 現像液と定着液が使用液型であることを特徴とする
処理方法。 14 自動現像処理装置の水洗槽が多室槽および多段向流
水洗方式を有することを特徴とする処理方法。5. A processing method characterized in that the opening ratio of the developing tank of the automatic development processing apparatus using the developing solution according to claim 1 is 0.04 cm -1 or less. 6 Development Concentration Solution and Fixing Concentration Solution consist of 1 part, and each Concentration Solution and Water are diluted to a working solution in each tank and supplied as a replenishing solution (immediately before mixing dilution method) . 7. A processing method, wherein the containers of the developing concentrate and the fixing concentrate according to claim 1 are integrated packaging materials. 8. A processing method comprising using an automatic developing machine having a rinse tank and a rinse roller (crossover roller) provided between the developing tank and the fixing tank using the developer of claim 1 and between the fixing tank and the washing tank. 9. A processing method characterized by using an automatic processor equipped with a stock tank of water in which various water redness preventive agents (antibacterial agents) are supplied to a washing tank and a rinse tank. 10 A processing method characterized by using an automatic processor having a solenoid valve installed at the drain of the washing tank. 11. The developer according to claim 1, wherein 70 mol% or more of all cations in the developer are potassium ions. 12. The developer according to claim 1, wherein the developer is powder. 13 A processing method characterized in that the developing solution and the fixing solution are used liquid types. 14 A processing method characterized in that the water washing tank of the automatic development processor has a multi-chamber tank and a multi-stage countercurrent water washing method.
【0124】[0124]
【発明の効果】ハロゲン化銀写真感光材料を自動現像機
でハイドロキノンモノスルフォネートもしくはその誘導
体現像主薬及び超加成性を示す補助現像主薬を含有する
現像液で処理することによって、低補充量化した場合に
も安定した写真性が得られた。The silver halide photographic light-sensitive material is treated with a developing solution containing a hydroquinone monosulfonate or its derivative developing agent and a super-additive auxiliary developing agent in an automatic developing machine to reduce the replenishment amount. Stable photographic properties were obtained even when the above was done.
Claims (3)
料を現像処理する方法において、該現像液中にハイドロ
キノンモノスルフォネートもしくはその誘導体と超加成
性を示す補助現像主薬を含有することを特徴とするハロ
ゲン化銀写真感光材料の処理方法。1. A method for developing an imagewise exposed silver halide photographic light-sensitive material, wherein the developing solution contains an auxiliary developing agent exhibiting superadditivity with hydroquinone monosulfonate or its derivative. A method for processing a silver halide photographic light-sensitive material, comprising:
は(II)で表される化合物を含有することを特徴とする
請求項1記載のハロゲン化銀写真感光材料の処理方法。 一般式(I) 【化1】 一般式(II) 【化2】 式中、R4 及びR5 はそれぞれ水素原子、炭素数1〜3
のアルキル基又はフェニル基を表し、R6 及びR7 はそ
れぞれ水素原子又は炭素数1〜3のアルキル基を表す。
m及びnはそれぞれ0、1又は2である。R8 はヒドロ
キシル基、アミノ基又は炭素数1〜3のアルキル基を表
す。R9 はR8 で表される基又は水素原子を表わす。M
は水素原子、アルカリ金属原子又はアンモニウム基を表
す。Xは、水素原子、炭素数1〜3のアルキル基、スル
ホニル基、アミノ基、アシル基又はアルコキシカルボニ
ル基を表す。2. The method for processing a silver halide photographic light-sensitive material according to claim 1, wherein the developer contains a compound represented by the following general formula (I) and / or (II). General formula (I) General formula (II) In the formula, R 4 and R 5 are each a hydrogen atom and have 1 to 3 carbon atoms.
Represents an alkyl group or phenyl group, and R 6 and R 7 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms.
m and n are 0, 1 or 2. R 8 represents a hydroxyl group, an amino group or an alkyl group having 1 to 3 carbon atoms. R 9 represents a group represented by R 8 or a hydrogen atom. M
Represents a hydrogen atom, an alkali metal atom or an ammonium group. X represents a hydrogen atom, an alkyl group having 1 to 3 carbon atoms, a sulfonyl group, an amino group, an acyl group or an alkoxycarbonyl group.
光材料1m2 当たり25ml以上200ml以下である
ことを特徴とする請求項1又は2記載のハロゲン化銀写
真感光材料の処理方法。3. The method of processing a silver halide photographic light-sensitive material according to claim 1, wherein the replenishing amount of the developing solution is 25 ml or more and 200 ml or less per 1 m 2 of the silver halide photographic light-sensitive material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9228195A JPH08286332A (en) | 1995-04-18 | 1995-04-18 | Processing method for silver halide photosensitive material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9228195A JPH08286332A (en) | 1995-04-18 | 1995-04-18 | Processing method for silver halide photosensitive material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH08286332A true JPH08286332A (en) | 1996-11-01 |
Family
ID=14050027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9228195A Pending JPH08286332A (en) | 1995-04-18 | 1995-04-18 | Processing method for silver halide photosensitive material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH08286332A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105669505A (en) * | 2016-02-25 | 2016-06-15 | 上海优合生物科技有限公司 | Preparing method of beta,beta'-dithiobis(dihydrocinnamicacid) |
-
1995
- 1995-04-18 JP JP9228195A patent/JPH08286332A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105669505A (en) * | 2016-02-25 | 2016-06-15 | 上海优合生物科技有限公司 | Preparing method of beta,beta'-dithiobis(dihydrocinnamicacid) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6350562B2 (en) | Concentrated fixing solution and method for processing silver halide photographic material using the same | |
| US5545508A (en) | Photographic silver halide developer compositions and process for forming photographic silver images | |
| US5508152A (en) | Method for processing a silver halide photographic material | |
| JPH10198002A (en) | Black-and-white development processing method | |
| JPH0667368A (en) | Method for developing black and white silver halide photographic light-sensitive material | |
| US5240823A (en) | Developer composition | |
| US5821040A (en) | Method for developing silver haide photographic material | |
| JPH10207019A (en) | Processing method of silver halide photographic material | |
| JPH0756286A (en) | Preserving method for developer and processing method | |
| JP2000075449A (en) | Method for developing silver halide photographic sensitive material | |
| JP3423504B2 (en) | Developing method of silver halide photographic material | |
| JP2824715B2 (en) | Processing method of black and white silver halide photographic material | |
| JP3476561B2 (en) | Processing method of silver halide photographic material | |
| JP3691205B2 (en) | Processing method of silver halide photographic light-sensitive material | |
| JPH08248581A (en) | Processing method of silver halide photographic light-sensitive material | |
| JPH0193737A (en) | Developing method | |
| JPH0752286B2 (en) | Development processing method of silver halide light-sensitive material | |
| JPH08171182A (en) | Method for storing and processing development replenisher for silver halide photographic light-sensitive material | |
| JPH07209826A (en) | Solid agent for fixing solution and method for processing silver halide photographic sensitive material using the same | |
| JPH06324435A (en) | Processing method for silver halide photographic sensitive material | |
| JPH05323525A (en) | Method of developing halogenized silver monochromatic photosensitive material | |
| JPH08248582A (en) | Processing method of silver halide photographic light-sensitive material | |
| JPH09101600A (en) | Method for processing silver halide photographic sensitive material | |
| JPH10293384A (en) | Processing method for silver halide photosensitive material | |
| JPH0651452A (en) | Treatment for black-and-white silver halide photographic sensitive material |